{ "version": "2.2", "instance": { "zk2636149.htm exhibit_99-1.htm": { "nsprefix": "evgn", "nsuri": "http://www.evogene.com/20260630", "dts": { "schema": { "local": [ "evgn-20260630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd", "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions-ea/rol_ifrs_ea-dim_2025-03-27.xsd", "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions/rol_full_ifrs-dim_2025-03-27.xsd", "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd", "https://xbrl.sec.gov/country/2025/country-2025.xsd", "https://xbrl.sec.gov/currency/2025/currency-2025.xsd", "https://xbrl.sec.gov/dei/2025/dei-2025.xsd", "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd", "https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd", "https://xbrl.sec.gov/exch/2025/exch-2025.xsd", "https://xbrl.sec.gov/naics/2025/naics-2025.xsd", "https://xbrl.sec.gov/sic/2025/sic-2025.xsd", "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" ] }, "calculationLink": { "local": [ "evgn-20260630_cal.xml" ] }, "definitionLink": { "local": [ "evgn-20260630_def.xml" ], "remote": [ "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions-ea/dim_ifrs_ea_2025-03-27_role-995000.xml", "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions/dim_full_ifrs_2025-03-27_role-995000.xml" ] }, "labelLink": { "local": [ "evgn-20260630_lab.xml" ] }, "presentationLink": { "local": [ "evgn-20260630_pre.xml" ] }, "inline": { "local": [ "exhibit_99-1.htm", "zk2636149.htm" ] } }, "keyStandard": 159, "keyCustom": 78, "axisStandard": 12, "axisCustom": 1, "memberStandard": 12, "memberCustom": 24, "hidden": { "total": 12, "http://xbrl.sec.gov/dei/2025": 4, "http://www.evogene.com/20260630": 8 }, "contextCount": 118, "entityCount": 1, "segmentCount": 36, "elementCount": 566, "unitCount": 6, "baseTaxonomies": { "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full": 440, "http://xbrl.sec.gov/dei/2025": 14 }, "report": { "R1": { "role": "http://www.evogene.com/role/DocumentAndEntityInformation", "longName": "0001 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "strong", "span", "span", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "zk2636149.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "strong", "span", "span", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "zk2636149.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition", "longName": "0002 - Statement - CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL POSITION", "shortName": "CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL POSITION", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "C_20260630", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "span", "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_20260630", "name": "evgn:RestrictedCashs", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "span", "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "unique": true } }, "R3": { "role": "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPositionParenthetical", "longName": "0003 - Statement - CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL POSITION (Parenthetical)", "shortName": "CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL POSITION (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "C_20260630", "name": "ifrs-full:ParValuePerShare", "unitRef": "NIS_per_share", "xsiNil": "false", "lang": null, "decimals": "1", "ancestors": [ "ifrs-full:ParValuePerShare", "span", "span", "span", "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_20260630", "name": "ifrs-full:NumberOfSharesAuthorised", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "ifrs-full:NumberOfSharesAuthorised", "span", "span", "span", "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "unique": true } }, "R4": { "role": "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss", "longName": "0004 - Statement - CONSOLIDATED INTERIM STATEMENTS OF PROFIT OR LOSS", "shortName": "CONSOLIDATED INTERIM STATEMENTS OF PROFIT OR LOSS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:Revenue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:ResearchAndDevelopmentExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "unique": true } }, "R5": { "role": "http://www.evogene.com/role/ConsolidatedStatementsOfChangesInEquity", "longName": "0005 - Statement - CONSOLIDATED INTERIM STATEMENTS OF CHANGES IN EQUITY", "shortName": "CONSOLIDATED INTERIM STATEMENTS OF CHANGES IN EQUITY", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "C_20241231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember", "name": "ifrs-full:Equity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20241231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember", "name": "ifrs-full:Equity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R6": { "role": "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows", "longName": "0006 - Statement - CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS", "shortName": "CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:ProfitLossFromContinuingOperations", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "unique": true } }, "R7": { "role": "http://www.evogene.com/role/General", "longName": "0007 - Disclosure - GENERAL", "shortName": "GENERAL", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.evogene.com/role/SignificantAccountingPolicies", "longName": "0008 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES", "shortName": "SIGNIFICANT ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.evogene.com/role/REVENUEFROMCONTRACTSWITHCUSTOMERS", "longName": "0009 - Disclosure - REVENUE FROM CONTRACTS WITH CUSTOMERS", "shortName": "REVENUE FROM CONTRACTS WITH CUSTOMERS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.evogene.com/role/OtherReceivablesAndPrepaidExpenses", "longName": "0010 - Disclosure - OTHER RECEIVABLES AND PREPAID EXPENSES", "shortName": "OTHER RECEIVABLES AND PREPAID EXPENSES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrants", "longName": "0011 - Disclosure - LIABILITIES IN RESPECT OF GOVERNMENT GRANTS", "shortName": "LIABILITIES IN RESPECT OF GOVERNMENT GRANTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.evogene.com/role/FinancialInstruments", "longName": "0012 - Disclosure - FINANCIAL INSTRUMENTS", "shortName": "FINANCIAL INSTRUMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.evogene.com/role/Share-BasedCompensation", "longName": "0013 - Disclosure - SHARE-BASED COMPENSATION", "shortName": "SHARE-BASED COMPENSATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.evogene.com/role/OperatingSegments", "longName": "0014 - Disclosure - OPERATING SEGMENTS", "shortName": "OPERATING SEGMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.evogene.com/role/ASSETSHELDFORSALEANDDISCONTINUEDOPERATIONS", "longName": "0015 - Disclosure - DISCONTINUED OPERATIONS", "shortName": "DISCONTINUED OPERATIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.evogene.com/role/SUBSEQUENTEVENTS", "longName": "0016 - Disclosure - SUBSEQUENT EVENTS", "shortName": "SUBSEQUENT EVENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.evogene.com/role/SignificantAccountingPoliciesPolicies", "longName": "9960701 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "17", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "evgn:DescriptionOfAccountingPolicyForBasisOfPresentationOfFinancialStatement", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630", "name": "evgn:DescriptionOfAccountingPolicyForBasisOfPresentationOfFinancialStatement", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.evogene.com/role/REVENUEFROMCONTRACTSWITHCUSTOMERSTables", "longName": "9960702 - Disclosure - REVENUE FROM CONTRACTS WITH CUSTOMERS (Tables)", "shortName": "REVENUE FROM CONTRACTS WITH CUSTOMERS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "18", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "evgn:DisclosureofDetailedInformationAboutofRevenuesByTimingOfRevenueRecognitionExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630", "name": "evgn:DisclosureofDetailedInformationAboutofRevenuesByTimingOfRevenueRecognitionExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.evogene.com/role/OtherReceivablesAndPrepaidExpensesTables", "longName": "9960703 - Disclosure - OTHER RECEIVABLES AND PREPAID EXPENSES (Tables)", "shortName": "OTHER RECEIVABLES AND PREPAID EXPENSES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "19", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "evgn:DisclosureOfDetailedInformationAboutOtherRecevablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630", "name": "evgn:DisclosureOfDetailedInformationAboutOtherRecevablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsTables", "longName": "9960704 - Disclosure - LIABILITIES IN RESPECT OF GOVERNMENT GRANTS (Tables)", "shortName": "LIABILITIES IN RESPECT OF GOVERNMENT GRANTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "20", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "evgn:DisclosureOfDetailedInformationAboutLiabilitiesInRespectOfGovernmentGrantsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630", "name": "evgn:DisclosureOfDetailedInformationAboutLiabilitiesInRespectOfGovernmentGrantsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.evogene.com/role/FinancialInstrumentsTables", "longName": "9960705 - Disclosure - FINANCIAL INSTRUMENTS (Tables)", "shortName": "FINANCIAL INSTRUMENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "21", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.evogene.com/role/Share-BasedCompensationTables", "longName": "9960706 - Disclosure - SHARE-BASED COMPENSATION (Tables)", "shortName": "SHARE-BASED COMPENSATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "22", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.evogene.com/role/OperatingSegmentsTables", "longName": "9960707 - Disclosure - OPERATING SEGMENTS (Tables)", "shortName": "OPERATING SEGMENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.evogene.com/role/ASSETSHELDFORSALEANDDISCONTINUEDOPERATIONSTables", "longName": "9960708 - Disclosure - DISCONTINUED OPERATIONS (Tables)", "shortName": "DISCONTINUED OPERATIONS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "evgn:DisclosureOfOperatingResultsAttributedToDiscontinuedOperationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630", "name": "evgn:DisclosureOfOperatingResultsAttributedToDiscontinuedOperationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.evogene.com/role/GeneralNarrativeDetails", "longName": "9960709 - Disclosure - GENERAL (Narrative) (Details)", "shortName": "GENERAL (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "25", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:ProfitLossFromOperatingActivities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_ifrsfullWarrantsMember", "name": "ifrs-full:FinanceCosts", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "div", "div", "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "unique": true } }, "R26": { "role": "http://www.evogene.com/role/REVENUEFROMCONTRACTSWITHCUSTOMERSScheduleOfRevenuesByTimingOfRevenueRecognitionDetails", "longName": "9960710 - Disclosure - REVENUE FROM CONTRACTS WITH CUSTOMERS (Schedule of revenues by timing of revenue recognition) (Details)", "shortName": "REVENUE FROM CONTRACTS WITH CUSTOMERS (Schedule of revenues by timing of revenue recognition) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "26", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "evgn:RevenueRecognizedAtPointInTime", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "td", "tr", "table", "div", "div", "evgn:DisclosureofDetailedInformationAboutofRevenuesByTimingOfRevenueRecognitionExplanatory", "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630", "name": "evgn:RevenueRecognizedAtPointInTime", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "td", "tr", "table", "div", "div", "evgn:DisclosureofDetailedInformationAboutofRevenuesByTimingOfRevenueRecognitionExplanatory", "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.evogene.com/role/OtherReceivablesAndPrepaidExpensesScheduleOfOtherReceivablesAndPrepaidExpensesDetails", "longName": "9960711 - Disclosure - OTHER RECEIVABLES AND PREPAID EXPENSES (Schedule of Other Receivables and Prepaid Expenses) (Details)", "shortName": "OTHER RECEIVABLES AND PREPAID EXPENSES (Schedule of Other Receivables and Prepaid Expenses) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "C_20260630", "name": "evgn:GovernmentAuthoritiesCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "evgn:DisclosureOfDetailedInformationAboutOtherRecevablesExplanatory", "div", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20260630", "name": "evgn:GovernmentAuthoritiesCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "evgn:DisclosureOfDetailedInformationAboutOtherRecevablesExplanatory", "div", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsNarrativeDetails", "longName": "9960712 - Disclosure - LIABILITIES IN RESPECT OF GOVERNMENT GRANTS (Narrative) (Details)", "shortName": "LIABILITIES IN RESPECT OF GOVERNMENT GRANTS (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "C_20260101to20260630_ifrsfullCategoriesOfRelatedPartiesAxis_evgnOfficeOfChiefScientistMember", "name": "evgn:PercentageOfRoyaltiesCompanyUndertookToPayDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630_ifrsfullCategoriesOfRelatedPartiesAxis_evgnOfficeOfChiefScientistMember", "name": "evgn:PercentageOfRoyaltiesCompanyUndertookToPayDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsScheduleOfLiabilitiesInRespectOfGovernmentGrantsDetails", "longName": "9960713 - Disclosure - LIABILITIES IN RESPECT OF GOVERNMENT GRANTS (Schedule of Liabilities in Respect of Government Grants) (Details)", "shortName": "LIABILITIES IN RESPECT OF GOVERNMENT GRANTS (Schedule of Liabilities in Respect of Government Grants) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "C_20251231", "name": "evgn:GovernmentGrant", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "evgn:DisclosureOfDetailedInformationAboutLiabilitiesInRespectOfGovernmentGrantsExplanatory", "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_20241231", "name": "evgn:GovernmentGrant", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "evgn:DisclosureOfDetailedInformationAboutLiabilitiesInRespectOfGovernmentGrantsExplanatory", "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "unique": true } }, "R30": { "role": "http://www.evogene.com/role/FINANCIALINSTRUMENTSScheduleOfFairValueOfFinancialLiabilitiesDetails", "longName": "9960714 - Disclosure - FINANCIAL INSTRUMENTS (Schedule of fair value of financial liabilities) (Details)", "shortName": "FINANCIAL INSTRUMENTS (Schedule of fair value of financial liabilities) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "evgn:ExerciseOfPreFundedWarrants", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630_ifrsfullClassesOfFinancialInstrumentsAxis_evgnWarrantsAndPreFundedWarrantsLiabilitiesMember", "name": "evgn:ChangeInFairValueOfPreFundedWarrants", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "div", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "unique": true } }, "R31": { "role": "http://www.evogene.com/role/FinancialInstrumentsNarrativeDetails", "longName": "9960715 - Disclosure - FINANCIAL INSTRUMENTS (Narrative) (Details)", "shortName": "FINANCIAL INSTRUMENTS (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted", "unitRef": "Percentage", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "td", "tr", "table", "div", "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_evgnWarrantsAndPreFundedWarrantsLiabilityMember", "name": "ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted", "unitRef": "Percentage", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "div", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "unique": true } }, "R32": { "role": "http://www.evogene.com/role/Share-BasedCompensationNarrativeDetails", "longName": "9960716 - Disclosure - SHARE-BASED COMPENSATION (Narrative) (Details)", "shortName": "SHARE-BASED COMPENSATION (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "evgn:ShareBasedCompensationExpensesRelatedToDiscontinuedOperations", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630", "name": "evgn:ShareBasedCompensationExpensesRelatedToDiscontinuedOperations", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.evogene.com/role/Share-BasedCompensationScheduleOfCompanysFinancialStatementsDetails", "longName": "9960717 - Disclosure - SHARE-BASED COMPENSATION (Schedule of Company's Financial Statements) (Details)", "shortName": "SHARE-BASED COMPENSATION (Schedule of Company's Financial Statements) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "evgn:IncreaseDecreaseThroughShareBasedPaymentTransactionsEquityHoldersOfCompany", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "ifrs-full:ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630", "name": "evgn:IncreaseDecreaseThroughShareBasedPaymentTransactionsEquityHoldersOfCompany", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "ifrs-full:ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.evogene.com/role/Share-BasedCompensationScheduleOfSummarizedNumberOfShareOptionsDetails", "longName": "9960718 - Disclosure - SHARE-BASED COMPENSATION (Schedule of Summarized Number of Share Options) (Details)", "shortName": "SHARE-BASED COMPENSATION (Schedule of Summarized Number of Share Options) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "C_20251231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_evgnEmployeesConsultantsDirectorsMember", "name": "ifrs-full:NumberOfOutstandingShareOptions", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20251231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_evgnEmployeesConsultantsDirectorsMember", "name": "ifrs-full:NumberOfOutstandingShareOptions", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.evogene.com/role/Share-BasedCompensationScheduleOfAssumptionsUsedToValueOptionsDetails", "longName": "9960720 - Disclosure - SHARE-BASED COMPENSATION (Schedule of Assumptions Used to Value Options) (Details)", "shortName": "SHARE-BASED COMPENSATION (Schedule of Assumptions Used to Value Options) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted", "unitRef": "Percentage", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "div", "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember", "name": "evgn:SuboptimalFactor", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "1", "ancestors": [ "td", "tr", "table", "div", "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "unique": true } }, "R36": { "role": "http://www.evogene.com/role/SHAREBASEDCOMPENSATIONScheduleOfRestrictedStockUnitsActivityDetails", "longName": "9960721 - Disclosure - SHARE-BASED COMPENSATION (Schedule of Restricted Stock Units activity) (Details)", "shortName": "SHARE-BASED COMPENSATION (Schedule of Restricted Stock Units activity) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "C_20251231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_evgnRestrictedStockUnitsMember", "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "div", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20251231_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_evgnRestrictedStockUnitsMember", "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "div", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.evogene.com/role/Share-BasedCompensationScheduleOfCompensationCostOfEquity-basedAwardsDetails", "longName": "9960722 - Disclosure - SHARE-BASED COMPENSATION (Schedule of Compensation Cost of Equity-Based Awards) (Details)", "shortName": "SHARE-BASED COMPENSATION (Schedule of Compensation Cost of Equity-Based Awards) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "evgn:CostOfRevenuesSharesBasedArrangement", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "ifrs-full:ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630", "name": "evgn:CostOfRevenuesSharesBasedArrangement", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "ifrs-full:ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesAndOperatingLossBySegmentsDetails", "longName": "9960723 - Disclosure - OPERATING SEGMENTS (Schedule of Revenues and Operating Loss by Segments) (Details)", "shortName": "OPERATING SEGMENTS (Schedule of Revenues and Operating Loss by Segments) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:Revenue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630", "name": "evgn:FinancingIncomeExpensesBySegment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "unique": true } }, "R39": { "role": "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesFromMajorCustomersDetails", "longName": "9960724 - Disclosure - OPERATING SEGMENTS (Schedule of Revenues from Major Customers) (Details)", "shortName": "OPERATING SEGMENTS (Schedule of Revenues from Major Customers) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:PercentageOfEntitysRevenue", "unitRef": "Percentage", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "div", "div", "ifrs-full:DisclosureOfGeographicalAreasExplanatory", "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630_srtMajorCustomersAxis_evgnCustomerShareholderMember", "name": "ifrs-full:PercentageOfEntitysRevenue", "unitRef": "Percentage", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "div", "div", "ifrs-full:DisclosureOfSegmentsMajorCustomersExplanatory", "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "unique": true } }, "R40": { "role": "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesBasedOnCustomersDetails", "longName": "9960725 - Disclosure - OPERATING SEGMENTS (Schedule of Revenues Based on Customers) (Details)", "shortName": "OPERATING SEGMENTS (Schedule of Revenues Based on Customers) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:PercentageOfEntitysRevenue", "unitRef": "Percentage", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "div", "div", "ifrs-full:DisclosureOfGeographicalAreasExplanatory", "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630_ifrsfullGeographicalAreasAxis_srtEuropeMember", "name": "ifrs-full:PercentageOfEntitysRevenue", "unitRef": "Percentage", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "div", "div", "ifrs-full:DisclosureOfGeographicalAreasExplanatory", "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "unique": true } }, "R41": { "role": "http://www.evogene.com/role/OperatingSegmentsScheduleOfPercentageOfNon-currentAssetsDetails", "longName": "9960726 - Disclosure - OPERATING SEGMENTS (Schedule of Percentage of Non-Current Assets) (Details)", "shortName": "OPERATING SEGMENTS (Schedule of Percentage of Non-Current Assets) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "evgn:PercentageOfEntityAccordingToLocation", "unitRef": "Percentage", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "div", "div", "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory", "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630", "name": "evgn:PercentageOfEntityAccordingToLocation", "unitRef": "Percentage", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "div", "div", "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory", "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.evogene.com/role/ASSETSHELDFORSALEANDDISCONTINUEDOPERATIONSNarrativeDetails", "longName": "9960728 - Disclosure - DISCONTINUED OPERATIONS (Narrative) (Details)", "shortName": "DISCONTINUED OPERATIONS (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "C_20250401to20250417", "name": "ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_20250401to20250417", "name": "ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.evogene.com/role/ASSETSHELDFORSALEANDDISCONTINUEDOPERATIONSDetails1", "longName": "9960729 - Disclosure - DISCONTINUED OPERATIONS (Details)", "shortName": "DISCONTINUED OPERATIONS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "C_20260101to20260630", "name": "ifrs-full:Revenue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_20260101to20260630_ifrsfullContinuingAndDiscontinuedOperationsAxis_ifrsfullDiscontinuedOperationsMember", "name": "ifrs-full:Revenue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "div", "evgn:DisclosureOfOperatingResultsAttributedToDiscontinuedOperationExplanatory", "div", "ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "unique": true } }, "R44": { "role": "http://www.evogene.com/role/SUBSEQUENTEVENTSNarrativeDetails", "longName": "9960730 - Disclosure - SUBSEQUENT EVENTS (Narrative) (Details)", "shortName": "SUBSEQUENT EVENTS (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "C_20260630", "name": "ifrs-full:ParValuePerShare", "unitRef": "NIS_per_share", "xsiNil": "false", "lang": null, "decimals": "1", "ancestors": [ "ifrs-full:ParValuePerShare", "span", "span", "span", "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_20260701to20260831_ifrsfullComponentsOfEquityAxis_evgnAtmOfferingMember_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_evgnSubsequentEventsMember", "name": "ifrs-full:WeightedAverageSharePrice2019", "unitRef": "USD_per_share", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "p", "div", "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "exhibit_99-1.htm", "unique": true } } }, "tag": { "evgn_AccumulatedLossAttributedToNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "AccumulatedLossAttributedToNoncontrollingInterests", "crdr": "debit", "presentation": [ "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Accumulated loss attributed to non-controlling interests.", "negatedLabel": "Accumulated loss attributed to non-controlling interests", "label": "Accumulated Loss Attributed To Noncontrolling Interests" } } }, "auth_ref": [] }, "evgn_AcquisitionOfPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "AcquisitionOfPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Acquisition of property, plant and equipment through non-cash activities.", "label": "Acquisition Of Property Plant And Equipment", "verboseLabel": "Acquisition of property, plant and equipment" } } }, "auth_ref": [] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]", "terseLabel": "Additional 402(v) Disclosure" } } }, "auth_ref": [ "r258" ] }, "dei_AddressTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AddressTypeDomain", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Address Type [Domain]", "documentation": "An entity may have several addresses for different purposes and this domain represents all such types." } } }, "auth_ref": [] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount", "terseLabel": "Adjustment to Compensation, Amount" } } }, "auth_ref": [ "r271" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]", "terseLabel": "Adjustment to Compensation:" } } }, "auth_ref": [ "r271" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]", "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "auth_ref": [ "r271" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]", "terseLabel": "Adjustment To PEO Compensation, Footnote" } } }, "auth_ref": [ "r271" ] }, "ifrs-full_AdjustedWeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustedWeightedAverageShares", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss" ], "lang": { "en-us": { "role": { "label": "Weighted average number of ordinary shares used in calculating diluted earnings per share", "terseLabel": "Weighted average number of ordinary shares used in computing diluted loss per share" } }, "en": { "role": { "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r19" ] }, "evgn_AdjustmentForIncreaseDecreaseInChangesInAssetAndLiabilityItems": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "AdjustmentForIncreaseDecreaseInChangesInAssetAndLiabilityItems", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 40.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for increase (decrease) in change in assets and liability items to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustment For Increase Decrease In Changes In Asset And Liability Items", "totalLabel": "Changes in asset and liability items" } } }, "auth_ref": [] }, "evgn_AdjustmentForRemeasurementOfPrefundedWarrantsAndWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "AdjustmentForRemeasurementOfPrefundedWarrantsAndWarrants", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": 1.0, "order": 100.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of remeasurement of pre-funded warrants and warrants.", "label": "Adjustment For Remeasurement Of Pre-funded Warrants And Warrants", "terseLabel": "Remeasurement of pre-funded warrants and warrants" } } }, "auth_ref": [] }, "evgn_AdjustmentForRevaluationOfConvertibleSafe": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "AdjustmentForRevaluationOfConvertibleSafe", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": 1.0, "order": 40.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of adjustment for revaluation of convertible SAFE.", "label": "Adjustment For Revaluation Of Convertible Safe", "terseLabel": "Remeasurement of convertible SAFE" } } }, "auth_ref": [] }, "evgn_AdjustmentsForAmortizationOfDeferredExpensesRelatedToIssuanceOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "AdjustmentsForAmortizationOfDeferredExpensesRelatedToIssuanceOfWarrants", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": 1.0, "order": 90.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of amortization of deferred expenses related to issuance of warrants", "label": "Adjustments For Amortization Of Deferred Expenses Related To Issuance Of Warrants", "terseLabel": "Amortization of deferred expenses related to issuance of warrants" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInInventories", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "evgn_AdjustmentForIncreaseDecreaseInChangesInAssetAndLiabilityItems", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for decrease (increase) in inventories", "terseLabel": "Decrease (increase) in inventories" } } }, "auth_ref": [ "r313" ] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "evgn_AdjustmentForIncreaseDecreaseInChangesInAssetAndLiabilityItems", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Decrease (increase) in other receivables", "terseLabel": "Decrease in other receivables and prepaid expenses" } } }, "auth_ref": [ "r313" ] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountReceivable", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "evgn_AdjustmentForIncreaseDecreaseInChangesInAssetAndLiabilityItems", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Decrease (increase) in trade receivables", "terseLabel": "Increase in trade receivables" } } }, "auth_ref": [ "r313" ] }, "ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForDepreciationAndAmortisationExpense", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation", "terseLabel": "Depreciation and amortization of property, plant and equipment and right-of-use-assets" } } }, "auth_ref": [ "r314" ] }, "evgn_AdjustmentsForExcessOfInitialFairValueOfPrefundedWarrantsOverTransactionProceeds": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "AdjustmentsForExcessOfInitialFairValueOfPrefundedWarrantsOverTransactionProceeds", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": -1.0, "order": 70.0 } }, "lang": { "en-us": { "role": { "documentation": "Represents the amount of excess of initial fair value of pre-funded warrants over transaction proceeds.", "negatedLabel": "Excess of initial fair value of pre-funded warrants over transaction proceeds", "label": "Adjustments For Excess Of Initial Fair Value Of Pre-funded Warrants Over Transaction Proceeds", "terseLabel": "Excess of initial fair value of pre-funded warrants over transaction proceeds" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForFinanceIncomeCost": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForFinanceIncomeCost", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": -1.0, "order": 60.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Net financing expenses (income)", "label": "Adjustments for finance income (cost)" } } }, "auth_ref": [ "r315" ] }, "ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": -1.0, "order": 50.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Gain from sale of property, plant and equipment", "label": "Adjustments for gain (loss) on disposals, property, plant and equipment" } }, "en": { "role": { "documentation": "Adjustments for gain (loss) on disposals of property, plant and equipment to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Property, plant and equipment; Disposals, property, plant and equipment]" } } }, "auth_ref": [ "r315" ] }, "ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, property, plant and equipment", "verboseLabel": "Impairment of property, plant and equipment" } }, "en": { "role": { "documentation": "Adjustments for impairment loss (reversal of impairment loss) on property, plant and equipment recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss; Property, plant and equipment]" } } }, "auth_ref": [ "r315" ] }, "ifrs-full_AdjustmentsForIncomeTaxExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForIncomeTaxExpense", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for income tax expense", "verboseLabel": "Taxes on income" } } }, "auth_ref": [ "r27" ] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "evgn_AdjustmentForIncreaseDecreaseInChangesInAssetAndLiabilityItems", "weight": 1.0, "order": 60.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) in deferred revenues and other advances", "terseLabel": "Decrease in deferred revenues and other advances" } }, "en": { "role": { "documentation": "Adjustments for the increase (decrease) in deferred income other than contract liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deferred income other than contract liabilities; Profit (loss)]" } } }, "auth_ref": [ "r313" ] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "evgn_AdjustmentForIncreaseDecreaseInChangesInAssetAndLiabilityItems", "weight": 1.0, "order": 40.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) in employees and payroll accruals", "verboseLabel": "Increase (decrease) in employees and payroll accruals" } }, "en": { "role": { "documentation": "Adjustments for increase (decrease) in employee benefit liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r315" ] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInOtherOperatingPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInOtherOperatingPayables", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "evgn_AdjustmentForIncreaseDecreaseInChangesInAssetAndLiabilityItems", "weight": 1.0, "order": 50.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) in other payables", "verboseLabel": "Decrease in other payables" } } }, "auth_ref": [ "r313" ] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "evgn_AdjustmentForIncreaseDecreaseInChangesInAssetAndLiabilityItems", "weight": 1.0, "order": 30.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) in trade payables", "terseLabel": "Decrease in trade payables" } } }, "auth_ref": [ "r313" ] }, "ifrs-full_AdjustmentsForReconcileProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForReconcileProfitLoss", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 50.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile profit (loss)", "totalLabel": "Adjustments to the profit or loss items" } } }, "auth_ref": [ "r23" ] }, "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForReconcileProfitLossAbstract", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to the profit or loss items:" } } }, "auth_ref": [] }, "evgn_AdjustmentsForShareBasedPaymentsExpenseRecognizedForServicesProvidedByEmployees": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "AdjustmentsForShareBasedPaymentsExpenseRecognizedForServicesProvidedByEmployees", "crdr": "debit", "calculation": { "http://www.evogene.com/role/Share-BasedCompensationScheduleOfCompanysFinancialStatementsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfCompanysFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for share-based payments to expense recognized for services provided by employees.", "label": "Adjustments For Share Based Payments Expense Recognized For Services Provided By Employees", "totalLabel": "Total share-based compensation", "verboseLabel": "Share-based compensation" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForSharebasedPayments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForSharebasedPayments", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": 1.0, "order": 30.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for share-based payments", "totalLabel": "Total share-based compensation", "verboseLabel": "Share-based compensation" } } }, "auth_ref": [ "r314" ] }, "evgn_AdjustmentsToReconcileNetLossToNetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "AdjustmentsToReconcileNetLossToNetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments To Reconcile Net Loss To Net Cash Provided By Used In Operating Activities Abstract", "verboseLabel": "Adjustments to reconcile loss to net cash used in operating activities:" } } }, "auth_ref": [] }, "ifrs-full_Advances": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Advances", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Advances received, representing contract liabilities for performance obligations satisfied at point in time", "verboseLabel": "Deferred revenues and other advances" } }, "en": { "role": { "documentation": "The amount of advances received representing contract liabilities for performance obligations satisfied at a point in time. [Refer: Contract liabilities; Performance obligations satisfied at point in time [member]]" } } }, "auth_ref": [ "r323", "r324" ] }, "srt_AfricaMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "AfricaMember", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsScheduleOfPercentageOfNon-currentAssetsDetails", "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesBasedOnCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Africa [Member]" } } }, "auth_ref": [] }, "evgn_AgPlenusLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "AgPlenusLtdMember", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "AgPlenus Ltd [Member]", "label": "Ag Plenus Ltd Member", "verboseLabel": "AgPlenus Ltd [Member]" } } }, "auth_ref": [] }, "evgn_AggregateGrantPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "AggregateGrantPaid", "crdr": "debit", "presentation": [ "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Aggregate grant paid.", "label": "Aggregate grant paid", "verboseLabel": "Aggregate grant paid" } } }, "auth_ref": [] }, "evgn_AggregateGrantReceivedIncludingAccruedInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "AggregateGrantReceivedIncludingAccruedInterest", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Aggregate grant received including accrued interest.", "label": "Aggregate Grant Received Including Accrued Interest", "verboseLabel": "Aggregate grant received including accrued interest" } } }, "auth_ref": [] }, "evgn_AggregateGrantReceivedLinkedToUsCpi": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "AggregateGrantReceivedLinkedToUsCpi", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Aggregate grant received linked to the US CPI.", "label": "Aggregate Grant Received Linked To Us Cpi", "verboseLabel": "Aggregate grant received linked to the US CPI" } } }, "auth_ref": [] }, "evgn_AggregateOfferingPrice": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "AggregateOfferingPrice", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents aggregate offering price.", "label": "Aggregate Offering Price", "verboseLabel": "Aggregate offering price" } } }, "auth_ref": [] }, "evgn_AggregateOfferingPriceSubsequentlyReduced": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "AggregateOfferingPriceSubsequentlyReduced", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents aggregate offering price subsequently reduced.", "label": "Aggregate Offering Price Subsequently Reduced", "verboseLabel": "Aggregate offering price subsequently reduced" } } }, "auth_ref": [] }, "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]", "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table" } } }, "auth_ref": [ "r305" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount", "terseLabel": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r229", "r240", "r250", "r283" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]", "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "auth_ref": [ "r232", "r243", "r253", "r286" ] }, "ecd_AggtPnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtPnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Pension Adjustments Service Cost [Member]", "terseLabel": "Aggregate Pension Adjustments Service Cost" } } }, "auth_ref": [ "r306" ] }, "evgn_AgreementAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "AgreementAxis", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails", "http://www.evogene.com/role/OPERATINGSEGMENTSDetails" ], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table.", "label": "Agreement [Axis]" } } }, "auth_ref": [] }, "evgn_AgreementDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "AgreementDomain", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails", "http://www.evogene.com/role/OPERATINGSEGMENTSDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Agreement ' axis if no other member is used.", "label": "Agreement [Domain]" } } }, "auth_ref": [] }, "evgn_AgricultureMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "AgricultureMember", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesAndOperatingLossBySegmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Agriculture [Member]", "label": "Agriculture [Member]" } } }, "auth_ref": [] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Adjustments to Compensation [Member]", "terseLabel": "All Adjustments to Compensation" } } }, "auth_ref": [ "r271" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Executive Categories [Member]", "terseLabel": "All Executive Categories" } } }, "auth_ref": [ "r278" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Individuals [Member]", "terseLabel": "All Individuals" } } }, "auth_ref": [ "r233", "r244", "r254", "r278", "r287", "r291", "r299" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "All Trading Arrangements [Member]", "terseLabel": "All Trading Arrangements" } } }, "auth_ref": [ "r297" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AmendmentFlag", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "evgn_AmountOfAtmOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "AmountOfAtmOffering", "crdr": "debit", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represent the amount of ATM offering", "label": "Amount Of Atm Offering" } } }, "auth_ref": [] }, "evgn_AmountOfInvestmentInFinancingRound": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "AmountOfInvestmentInFinancingRound", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of investment in financing round.", "label": "Amount Of Investment In Financing Round", "terseLabel": "Amount of investment in financing round" } } }, "auth_ref": [] }, "evgn_AmountOfInvestmentUnderCollaborationAgreement": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "AmountOfInvestmentUnderCollaborationAgreement", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "It represents amount of investment under collaboration agreement.", "label": "Amount Of Investment Under Collaboration Agreement", "verboseLabel": "Amount of investment under collaboration agreement" } } }, "auth_ref": [] }, "evgn_AmountsRecordedInProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "AmountsRecordedInProfitOrLoss", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsScheduleOfLiabilitiesInRespectOfGovernmentGrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amounts recorded in profit or loss.", "label": "Amounts Recorded In Profit Or Loss", "verboseLabel": "Amounts recorded in profit or loss" } } }, "auth_ref": [] }, "ifrs-full_Assets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Assets", "totalLabel": "TOTAL ASSETS" } }, "en": { "role": { "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r52", "r53", "r54", "r98", "r102", "r150", "r151", "r172" ] }, "evgn_AssetsHeldForSaleAndDiscontinuedOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "AssetsHeldForSaleAndDiscontinuedOperationsAbstract", "lang": { "en-us": { "role": { "label": "Assets Held For Sale And Discontinued Operations [Abstract]" } } }, "auth_ref": [] }, "evgn_AssetsHeldForSaleAndDiscontinuedOperationsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "AssetsHeldForSaleAndDiscontinuedOperationsLineItems", "presentation": [ "http://www.evogene.com/role/ASSETSHELDFORSALEANDDISCONTINUEDOPERATIONSDetails1" ], "lang": { "en-us": { "role": { "documentation": "Assets Held For Sale And Discontinued Operations [Line Items]", "label": "Assets Held For Sale And Discontinued Operations [Line Items]" } } }, "auth_ref": [] }, "evgn_AssetsHeldForSaleAndDiscontinuedOperationsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "AssetsHeldForSaleAndDiscontinuedOperationsTable", "presentation": [ "http://www.evogene.com/role/ASSETSHELDFORSALEANDDISCONTINUEDOPERATIONSDetails1" ], "lang": { "en-us": { "role": { "documentation": "Assets Held For Sale And Discontinued Operations [Table]", "label": "Assets Held For Sale And Discontinued Operations [Table]" } } }, "auth_ref": [] }, "evgn_AtmOfferingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "AtmOfferingMember", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails", "http://www.evogene.com/role/SUBSEQUENTEVENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "ATM offering.", "label": "Atm Offering [Member]", "terseLabel": "ATM offering [Member]" } } }, "auth_ref": [] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AuditorFirmId", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r223", "r224", "r236" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AuditorLocation", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r223", "r224", "r236" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AuditorName", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r223", "r224", "r236" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price", "terseLabel": "Exercise Price" } } }, "auth_ref": [ "r294" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value", "terseLabel": "Fair Value as of Grant Date" } } }, "auth_ref": [ "r295" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]", "terseLabel": "Award Timing Disclosures" } } }, "auth_ref": [ "r290" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]", "terseLabel": "Award Timing, How MNPI Considered" } } }, "auth_ref": [ "r290" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]", "terseLabel": "Award Timing Method" } } }, "auth_ref": [ "r290" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]", "terseLabel": "Award Timing MNPI Considered" } } }, "auth_ref": [ "r290" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]", "terseLabel": "Award Timing MNPI Disclosure" } } }, "auth_ref": [ "r290" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]", "terseLabel": "Award Timing Predetermined" } } }, "auth_ref": [ "r290" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "terseLabel": "Award Type" } } }, "auth_ref": [] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount", "terseLabel": "Underlying Securities" } } }, "auth_ref": [ "r293" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r292" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]", "terseLabel": "Awards Close in Time to MNPI Disclosures" } } }, "auth_ref": [ "r291" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]", "terseLabel": "Awards Close in Time to MNPI Disclosures, Table" } } }, "auth_ref": [ "r291" ] }, "evgn_BaseForRoyaltyPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "BaseForRoyaltyPayments", "crdr": "debit", "presentation": [ "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents about base for royalty payments amount.", "label": "Base For Royalty Payments", "terseLabel": "Base for royalty payments" } } }, "auth_ref": [] }, "ifrs-full_BasicEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BasicEarningsLossPerShare", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss" ], "lang": { "en-us": { "role": { "label": "Basic loss per share, attributable to equity holders of the Company" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)." } } }, "auth_ref": [ "r16", "r17" ] }, "ifrs-full_BasicEarningsLossPerShareFromContinuingOperations": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BasicEarningsLossPerShareFromContinuingOperations", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss" ], "lang": { "en-us": { "role": { "commentaryGuidance": "The reported value should be tagged twice, with both this element and the element \u2018Diluted earnings (loss) per share from continuing operations' when: (a) basic and diluted earnings per share are equal; and (b) an entity presents one line item to accomplish the dual presentation requirement of paragraph 67 of IAS 33.", "label": "Basic earnings (loss) per share from continuing operations", "terseLabel": "Basic loss per share from continuing operations, attributable to equity holders of the Company", "totalLabel": "Total basic earnings (loss) per share" } }, "en": { "role": { "documentation": "Basic earnings (loss) per share from continuing operations. [Refer: Basic earnings (loss) per share; Continuing operations, unless line item indicates otherwise [member]]" } } }, "auth_ref": [ "r16", "r17" ] }, "ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BasicEarningsLossPerShareFromDiscontinuedOperations", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss" ], "lang": { "en-us": { "role": { "label": "Basic loss per share from discontinued operations, attributable to equity holders of the Company" } }, "en": { "role": { "documentation": "Basic earnings (loss) per share from discontinued operations. [Refer: Basic earnings (loss) per share; Discontinued operations [member]]" } } }, "auth_ref": [ "r17", "r18" ] }, "evgn_BinationalIndustrialResearchAndDevelopmentFoundationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "BinationalIndustrialResearchAndDevelopmentFoundationMember", "presentation": [ "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "BIRD [Member]", "label": "Binational Industrial Research And Development Foundation Member", "verboseLabel": "BIRD [Member]" } } }, "auth_ref": [] }, "evgn_BiomicaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "BiomicaMember", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Biomica [Member]", "label": "Biomica [Member]", "verboseLabel": "Biomica Ltd [Member]" } } }, "auth_ref": [] }, "ifrs-full_BottomOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BottomOfRangeMember", "presentation": [ "http://www.evogene.com/role/FinancialInstrumentsNarrativeDetails", "http://www.evogene.com/role/Share-BasedCompensationScheduleOfAssumptionsUsedToValueOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Bottom of range [member]" } }, "en": { "role": { "documentation": "This member stands for the bottom of a range." } } }, "auth_ref": [ "r29", "r55", "r64", "r74", "r122", "r200", "r201", "r318" ] }, "ifrs-full_BusinessCombinationsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BusinessCombinationsAxis", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails", "http://www.evogene.com/role/OPERATINGSEGMENTSDetails" ], "lang": { "en-us": { "role": { "label": "Business combinations [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r81", "r144" ] }, "ifrs-full_BusinessCombinationsDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BusinessCombinationsDomain", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails", "http://www.evogene.com/role/OPERATINGSEGMENTSDetails" ], "lang": { "en-us": { "role": { "label": "Business combinations [domain]" } }, "en": { "role": { "documentation": "This member stands for the standard value for the 'Business combinations' axis if no other member is used." } } }, "auth_ref": [ "r81", "r82", "r144" ] }, "dei_BusinessContactMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "BusinessContactMember", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Business Contact [Member]", "documentation": "Business contact for the entity" } } }, "auth_ref": [ "r224", "r236" ] }, "evgn_CancelledAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "CancelledAmount", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Cancelled amount.", "label": "Cancelled Amount", "verboseLabel": "Cancelled amount" } } }, "auth_ref": [] }, "evgn_CanonicLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "CanonicLtdMember", "presentation": [ "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "This member is stand for Canonic Ltd.", "label": "Canonic Ltd [Member]" } } }, "auth_ref": [] }, "ifrs-full_CapitalReserve": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CapitalReserve", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Share premium and other capital reserves" } }, "en": { "role": { "documentation": "A component of equity representing the capital reserves." } } }, "auth_ref": [ "r323" ] }, "ifrs-full_CashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashAndCashEquivalents", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows", "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "periodEndLabel": "Cash and cash equivalents, end of the period", "periodStartLabel": "Cash and cash equivalents, beginning of the period", "label": "Cash and cash equivalents", "totalLabel": "Cash and cash equivalents" } }, "en": { "role": { "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]" } } }, "auth_ref": [ "r30", "r48", "r123", "r168" ] }, "evgn_CashAndCashEquivalentsPresentedInAssetsHeldForSale": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "CashAndCashEquivalentsPresentedInAssetsHeldForSale", "crdr": "debit", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Represents amount of cash and cash equivalents presented in assets held for sale.", "label": "Cash And Cash Equivalents Presented In Assets Held For Sale", "terseLabel": "Cash and cash equivalents presented in assets held for sale", "verboseLabel": "Cash and cash equivalents" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) decrease (increase) in short-term deposits and investments", "verboseLabel": "Investment in bank deposits, net" } }, "en": { "role": { "documentation": "The cash inflow (outflow) due to a decrease (increase) in short-term deposits and investments." } } }, "auth_ref": [ "r311" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 30.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net cash provided by financing activities", "totalLabel": "Net cash provided by financing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity, from continuing and discontinued operations." } } }, "auth_ref": [ "r22", "r31" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) financing activities, continuing operations", "totalLabel": "Net cash provided by continuing financing activities", "verboseLabel": "Net cash provided by (used in) continuing financing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) the entity's financing activities, related to continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Cash flows from (used in) financing activities]" } } }, "auth_ref": [ "r85" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) financing activities, discontinued operations", "verboseLabel": "Net cash provided by (used in) financing activities of discontinued operations" } }, "en": { "role": { "documentation": "The cash flows from (used in) the entity's financing activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) financing activities]" } } }, "auth_ref": [ "r85" ] }, "ifrs-full_CashFlowsFromUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) investing activities", "totalLabel": "Net cash provided by (used in) investing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents, from continuing and discontinued operations." } } }, "auth_ref": [ "r22", "r31" ] }, "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:", "verboseLabel": "Cash flows from investing activities:" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) investing activities, continuing operations", "totalLabel": "Net cash provided by (used in) continuing investing activities", "verboseLabel": "Net cash provided by (used in) continuing investing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) the entity's investing activities, related to continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Cash flows from (used in) investing activities]" } } }, "auth_ref": [ "r85" ] }, "ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) investing activities, discontinued operations", "verboseLabel": "Net cash used in investing activities of discontinued operations, mainly due to investment in bank deposits, net" } }, "en": { "role": { "documentation": "The cash flows from (used in) the entity's investing activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) investing activities]" } } }, "auth_ref": [ "r85" ] }, "ifrs-full_CashFlowsFromUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivities", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows", "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) operating activities", "terseLabel": "Net operating cash outflows", "totalLabel": "Net cash used in operating activities" } } }, "auth_ref": [ "r22", "r31" ] }, "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) operating activities, continuing operations", "verboseLabel": "Net cash used in continuing operating activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) the entity's operating activities, related to continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Cash flows from (used in) operating activities]" } } }, "auth_ref": [ "r85" ] }, "ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) operating activities, discontinued operations", "verboseLabel": "Net cash used in operating activities of discontinued operations" } }, "en": { "role": { "documentation": "The cash flows from (used in) the entity's operating activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) operating activities]" } } }, "auth_ref": [ "r85" ] }, "evgn_CashInflowFromIssuingShares": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "CashInflowFromIssuingShares", "crdr": "debit", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of cash inflow from issuing shares.", "label": "Cash Inflow From Issuing Shares", "verboseLabel": "Cash inflow from issuing shares" } } }, "auth_ref": [] }, "evgn_CashReceivedPaidDuringYearAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "CashReceivedPaidDuringYearAbstract", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash Received Paid During Year Abstract", "verboseLabel": "Cash received (paid) during the period for:" } } }, "auth_ref": [] }, "ifrs-full_CategoriesOfRelatedPartiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CategoriesOfRelatedPartiesAxis", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails", "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Categories of related parties [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r9", "r129" ] }, "ifrs-full_CategoriesOfRelatedPartiesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CategoriesOfRelatedPartiesDomain", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails", "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Categories of related parties [domain]" } }, "en": { "role": { "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used." } } }, "auth_ref": [ "r9", "r129" ] }, "evgn_ChangeInFairValueOfExistingWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ChangeInFairValueOfExistingWarrants", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/FINANCIALINSTRUMENTSScheduleOfFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "It represents as a change in fair value of existing warrants.", "label": "Change In Fair Value Of Existing Warrants", "verboseLabel": "Change in fair value of Existing Warrants" } } }, "auth_ref": [] }, "evgn_ChangeInFairValueOfNewWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ChangeInFairValueOfNewWarrants", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/FINANCIALINSTRUMENTSScheduleOfFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "It represents as a change in fair value of New Warrants.", "label": "Change In Fair Value Of New Warrants", "verboseLabel": "Change in fair value of New Warrants" } } }, "auth_ref": [] }, "evgn_ChangeInFairValueOfPreFundedWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ChangeInFairValueOfPreFundedWarrants", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/FINANCIALINSTRUMENTSScheduleOfFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "It represents as a change in fair value of pre funded warrants.", "label": "Change In Fair Value Of Pre Funded Warrants", "verboseLabel": "Change in fair value of pre-funded warrants" } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]", "terseLabel": "Changed Peer Group, Footnote" } } }, "auth_ref": [ "r269" ] }, "evgn_ChangesInAssetAndLiabilityItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ChangesInAssetAndLiabilityItemsAbstract", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes In Asset And Liability Items Abstract", "verboseLabel": "Changes in asset and liability items:" } } }, "auth_ref": [] }, "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]", "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year" } } }, "auth_ref": [ "r266" ] }, "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]", "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested" } } }, "auth_ref": [ "r264" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CityAreaCode", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "ifrs-full_ClassesOfFinancialInstrumentsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfFinancialInstrumentsAxis", "presentation": [ "http://www.evogene.com/role/FINANCIALINSTRUMENTSScheduleOfFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Classes of financial instruments [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r89", "r90", "r91", "r92", "r146", "r147" ] }, "ifrs-full_ClassesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfFinancialInstrumentsDomain", "presentation": [ "http://www.evogene.com/role/FINANCIALINSTRUMENTSScheduleOfFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Classes of financial instruments [domain]" } }, "en": { "role": { "documentation": "This member stands for aggregated classes of financial instruments. Financial instruments are contracts that give rise to a financial asset of one entity and a financial liability or equity instrument of another entity. It also represents the standard value for the 'Classes of financial instruments' axis if no other member is used. [Refer: Financial assets; Financial liabilities]" } } }, "auth_ref": [ "r89", "r90", "r91", "r92", "r146", "r147" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount", "terseLabel": "Company Selected Measure Amount" } } }, "auth_ref": [ "r270" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name", "terseLabel": "Company Selected Measure Name" } } }, "auth_ref": [ "r270" ] }, "evgn_CollaborationAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "CollaborationAgreementMember", "presentation": [ "http://www.evogene.com/role/OPERATINGSEGMENTSDetails" ], "lang": { "en-us": { "role": { "documentation": "Collaboration Agreement [Member]", "label": "Collaboration Agreement [Member]" } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Company Selected Measure" } } }, "auth_ref": [ "r275" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]", "terseLabel": "Compensation Actually Paid vs. Net Income" } } }, "auth_ref": [ "r274" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Other Measure" } } }, "auth_ref": [ "r276" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]", "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "auth_ref": [ "r273" ] }, "evgn_CompensationCostRelatedToDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "CompensationCostRelatedToDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount represents compensation cost related to discontinued operations.", "label": "Compensation Cost Related To Discontinued Operations", "terseLabel": "Compensation cost related to discontinued operations" } } }, "auth_ref": [] }, "ifrs-full_ComponentsOfEquityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComponentsOfEquityAxis", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfChangesInEquity", "http://www.evogene.com/role/GeneralNarrativeDetails", "http://www.evogene.com/role/SUBSEQUENTEVENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Components of equity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r162" ] }, "ifrs-full_ComponentsOfEquityDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComponentsOfEquityDomain", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfChangesInEquity", "http://www.evogene.com/role/GeneralNarrativeDetails", "http://www.evogene.com/role/SUBSEQUENTEVENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Equity [Member]" } }, "en": { "role": { "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used." } } }, "auth_ref": [ "r162" ] }, "evgn_ConsiderationFromOptionExercises": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ConsiderationFromOptionExercises", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents amount of total consideration.", "label": "Consideration From Option Exercises", "verboseLabel": "Total consideration" } } }, "auth_ref": [] }, "evgn_ConsiderationReceivedForDisposalOfSubsidiary": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ConsiderationReceivedForDisposalOfSubsidiary", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents amount of total consideration.", "label": "Consideration Received For Disposal Of Subsidiary", "terseLabel": "Consideration received for sale of project" } } }, "auth_ref": [] }, "dei_ContactPersonnelName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "ContactPersonnelName", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Contact Personnel Name", "documentation": "Name of contact personnel" } } }, "auth_ref": [] }, "ifrs-full_ContinuingAndDiscontinuedOperationsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ContinuingAndDiscontinuedOperationsAxis", "presentation": [ "http://www.evogene.com/role/ASSETSHELDFORSALEANDDISCONTINUEDOPERATIONSDetails1" ], "lang": { "en-us": { "role": { "label": "Continuing and discontinued operations [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r86" ] }, "ifrs-full_ContinuingOperationsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ContinuingOperationsMember", "presentation": [ "http://www.evogene.com/role/ASSETSHELDFORSALEANDDISCONTINUEDOPERATIONSDetails1" ], "lang": { "en-us": { "role": { "label": "Continuing operations, unless line item indicates otherwise [member]" } }, "en": { "role": { "documentation": "This member stands for components of the entity that are not discontinued operations. A component of an entity comprises operations and cash flows that can be clearly distinguished, operationally and for financial reporting purposes, from the rest of the entity. This meaning may be overridden for line items which are either intrinsically related to discontinued operations (or disposal groups held for sale), or which are typically reported for the aggregate of continuing and discontinued. This member also represents the standard value for the 'Continuing and discontinued operations' axis if no other member is used. [Refer: Discontinued operations [member]; Aggregate continuing and discontinued operations [member]]" } } }, "auth_ref": [ "r86" ] }, "evgn_ConvertibleSafe": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ConvertibleSafe", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 0.0 } }, "lang": { "en-us": { "role": { "documentation": "Represents the amount of convertible safe.", "label": "Convertible Safe", "terseLabel": "Convertible SAFE" } } }, "auth_ref": [] }, "evgn_ConvertibleSafeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ConvertibleSafeMember", "presentation": [ "http://www.evogene.com/role/FINANCIALINSTRUMENTSScheduleOfFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Convertible SAFE [Member].", "label": "Convertible Safe [Member]", "verboseLabel": "Convertible SAFE [Member]" } } }, "auth_ref": [] }, "evgn_CostOfRevenuesSharesBasedArrangement": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "CostOfRevenuesSharesBasedArrangement", "crdr": "debit", "calculation": { "http://www.evogene.com/role/Share-BasedCompensationScheduleOfCompensationCostOfEquity-basedAwardsDetails": { "parentTag": "ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfCompensationCostOfEquity-basedAwardsDetails" ], "lang": { "en-us": { "role": { "documentation": "Cost of revenues related with share based compensation.", "label": "Cost Of Revenues Shares Based Arrangement", "terseLabel": "Cost of revenues" } } }, "auth_ref": [] }, "ifrs-full_CostOfSales": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CostOfSales", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss": { "parentTag": "ifrs-full_GrossProfit", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/ASSETSHELDFORSALEANDDISCONTINUEDOPERATIONSDetails1", "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss" ], "lang": { "en-us": { "role": { "label": "Cost of sales", "totalLabel": "Total cost of revenues", "verboseLabel": "Cost of revenues" } } }, "auth_ref": [ "r159", "r191" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "verboseLabel": "Document And Entity Information", "documentation": "Cover page." } } }, "auth_ref": [] }, "ifrs-full_CurrentAdvancesToSuppliers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentAdvancesToSuppliers", "crdr": "debit", "calculation": { "http://www.evogene.com/role/OtherReceivablesAndPrepaidExpensesScheduleOfOtherReceivablesAndPrepaidExpensesDetails": { "parentTag": "ifrs-full_OtherCurrentReceivables", "weight": 1.0, "order": 60.0 } }, "presentation": [ "http://www.evogene.com/role/OtherReceivablesAndPrepaidExpensesScheduleOfOtherReceivablesAndPrepaidExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Current advances to suppliers", "verboseLabel": "Suppliers' advances" } }, "en": { "role": { "documentation": "The amount of current advances made to suppliers before goods or services are received." } } }, "auth_ref": [ "r322" ] }, "ifrs-full_CurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentAssets", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current assets", "totalLabel": "Total current assets" } }, "en": { "role": { "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]" } } }, "auth_ref": [ "r41", "r173", "r199" ] }, "ifrs-full_CurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentAssetsAbstract", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "CURRENT ASSETS:" } } }, "auth_ref": [] }, "evgn_CurrentConvertibleSafe": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "CurrentConvertibleSafe", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 60.0 } }, "lang": { "en-us": { "role": { "documentation": "Represents the amount of Current Convertible Safe", "label": "Current Convertible Safe" } } }, "auth_ref": [] }, "evgn_CurrentDeferredExpensesRelatedToIssuanceOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "CurrentDeferredExpensesRelatedToIssuanceOfWarrants", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 30.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of current deferred expenses related to issuance of warrants.", "label": "Current Deferred Expenses Related To Issuance Of Warrants", "terseLabel": "Deferred expenses related to issuance of warrants" } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "ifrs-full_CurrentGovernmentGrants": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentGovernmentGrants", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Liabilities in respect of government grants" } }, "en": { "role": { "documentation": "The amount of current government grants recognised in the statement of financial position as deferred income. [Refer: Government [member]; Government grants]" } } }, "auth_ref": [ "r323" ] }, "ifrs-full_CurrentInterestReceivable": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentInterestReceivable", "crdr": "debit", "calculation": { "http://www.evogene.com/role/OtherReceivablesAndPrepaidExpensesScheduleOfOtherReceivablesAndPrepaidExpensesDetails": { "parentTag": "ifrs-full_OtherCurrentReceivables", "weight": 1.0, "order": 30.0 } }, "presentation": [ "http://www.evogene.com/role/OtherReceivablesAndPrepaidExpensesScheduleOfOtherReceivablesAndPrepaidExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued bank interests" } }, "en": { "role": { "documentation": "The amount of current interest receivable. [Refer: Interest receivable]" } } }, "auth_ref": [ "r322" ] }, "ifrs-full_CurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 70.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current maturities of lease liabilities", "terseLabel": "Lease liabilities" } }, "en": { "role": { "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r62" ] }, "ifrs-full_CurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentLiabilities", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current liabilities", "totalLabel": "Total current liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period." } } }, "auth_ref": [ "r43", "r174", "r199" ] }, "ifrs-full_CurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentLiabilitiesAbstract", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "CURRENT LIABILITIES:" } } }, "auth_ref": [] }, "ifrs-full_CurrentPrepaidExpenses": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentPrepaidExpenses", "crdr": "debit", "calculation": { "http://www.evogene.com/role/OtherReceivablesAndPrepaidExpensesScheduleOfOtherReceivablesAndPrepaidExpensesDetails": { "parentTag": "ifrs-full_OtherCurrentReceivables", "weight": 1.0, "order": 40.0 } }, "presentation": [ "http://www.evogene.com/role/OtherReceivablesAndPrepaidExpensesScheduleOfOtherReceivablesAndPrepaidExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses" } }, "en": { "role": { "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised." } } }, "auth_ref": [ "r322" ] }, "ifrs-full_CurrentProvisionsForEmployeeBenefits": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentProvisionsForEmployeeBenefits", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 40.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Employees and payroll accruals" } }, "en": { "role": { "documentation": "The amount of current provisions for employee benefits. [Refer: Provisions for employee benefits]" } } }, "auth_ref": [ "r157", "r175" ] }, "ifrs-full_CurrentTradeReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentTradeReceivables", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Trade receivables", "terseLabel": "Trade receivables" } }, "en": { "role": { "documentation": "The amount of current trade receivables. [Refer: Trade receivables]" } } }, "auth_ref": [ "r210", "r215", "r216" ] }, "ifrs-full_CurrentWarrantLiability": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentWarrantLiability", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 50.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current warrant liability", "verboseLabel": "Warrants liability" } }, "en": { "role": { "documentation": "The amount of current warrant liabilities. [Refer: Warrant liability]" } } }, "auth_ref": [ "r323" ] }, "evgn_CustomerBMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "CustomerBMember", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesFromMajorCustomersDetails" ], "lang": { "en-us": { "role": { "documentation": "Customer B [Member]", "label": "Customer B Member", "verboseLabel": "Customer B - Industrial [Member]" } } }, "auth_ref": [] }, "evgn_CustomerCMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "CustomerCMember", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesFromMajorCustomersDetails" ], "lang": { "en-us": { "role": { "documentation": "Customer C [Member]", "label": "Customer C Member", "verboseLabel": "Customer C- Agriculture [Member]" } } }, "auth_ref": [] }, "evgn_CustomerDMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "CustomerDMember", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesFromMajorCustomersDetails" ], "lang": { "en-us": { "role": { "documentation": "Customer D [Member]", "label": "Customer D [Member]", "verboseLabel": "Customer D- Unallocated [Member]" } } }, "auth_ref": [] }, "evgn_CustomerShareholderMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "CustomerShareholderMember", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesFromMajorCustomersDetails" ], "lang": { "en-us": { "role": { "documentation": "Customer A shareholder [Member]", "label": "Customer Shareholder Member", "verboseLabel": "Customer A - Industrial [Member]" } } }, "auth_ref": [] }, "evgn_DefinitiveAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "DefinitiveAgreementMember", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stand for definitive agreement.", "label": "Definitive Agreement [Member]", "verboseLabel": "Definitive Agreement [Member]" } } }, "auth_ref": [] }, "evgn_DerecognitionOfPropertyPlantAndEquipmentUnderAFinanceLease": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "DerecognitionOfPropertyPlantAndEquipmentUnderAFinanceLease", "crdr": "debit", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Represent the amount of Derecognition of property, plant and equipment under a finance lease", "label": "Derecognition Of Property, Plant And Equipment Under A Finance Lease", "verboseLabel": "Derecognition of property, plant and equipment under a finance lease" } } }, "auth_ref": [] }, "evgn_DescriptionOfAccountingPolicyForBasisOfPresentationOfFinancialStatement": { "xbrltype": "textBlockItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "DescriptionOfAccountingPolicyForBasisOfPresentationOfFinancialStatement", "presentation": [ "http://www.evogene.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "The description of the entity's material accounting policy information for Basis Of Presentation Of The Financial Statement", "label": "Description Of Accounting Policy For Basis Of Presentation Of Financial Statement", "terseLabel": "Basis of presentation of the financial statements" } } }, "auth_ref": [] }, "evgn_DescriptionOfAccountingPolicyForExplanatoryAssetsOrDisposalGroupHeldForSaleAndDiscontinuedOperations": { "xbrltype": "textBlockItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "DescriptionOfAccountingPolicyForExplanatoryAssetsOrDisposalGroupHeldForSaleAndDiscontinuedOperations", "presentation": [ "http://www.evogene.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "Represent the member of Assets or disposal group held for sale and discontinued operations", "label": "Description Of Accounting Policy For Explanatory Assets Or Disposal Group Held For Sale And Discontinued Operations", "verboseLabel": "Assets or disposal group held for sale and discontinued operations" } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted", "presentation": [ "http://www.evogene.com/role/FinancialInstrumentsNarrativeDetails", "http://www.evogene.com/role/Share-BasedCompensationScheduleOfAssumptionsUsedToValueOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Expected volatility, share options granted", "terseLabel": "Expected volatility of the share prices", "verboseLabel": "Expected volatility of the share prices (%)" } }, "en": { "role": { "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time." } } }, "auth_ref": [ "r76" ] }, "ifrs-full_DescriptionOfOptionLifeShareOptionsGranted": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DescriptionOfOptionLifeShareOptionsGranted", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Maturity for share option and incentive plans" } }, "en": { "role": { "documentation": "The option life of share options granted." } } }, "auth_ref": [ "r76" ] }, "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted", "presentation": [ "http://www.evogene.com/role/FinancialInstrumentsNarrativeDetails", "http://www.evogene.com/role/Share-BasedCompensationScheduleOfAssumptionsUsedToValueOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Risk free interest rate, share options granted", "terseLabel": "Risk-free interest rate", "verboseLabel": "Risk-free interest rate (%)" } }, "en": { "role": { "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]" } } }, "auth_ref": [ "r76" ] }, "ifrs-full_DilutedEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DilutedEarningsLossPerShare", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss" ], "lang": { "en-us": { "role": { "label": "Diluted loss per share, attributable to equity holders of the Company" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r16", "r17" ] }, "ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DilutedEarningsLossPerShareFromContinuingOperations", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss" ], "lang": { "en-us": { "role": { "commentaryGuidance": "The reported value should be tagged twice, with both this element and the element \u2018Basic earnings (loss) per share from continuing operations' when: (a) basic and diluted earnings per share are equal; and (b) an entity presents one line item to accomplish the dual presentation requirement of paragraph 67 of IAS 33.", "label": "Diluted earnings (loss) per share from continuing operations", "terseLabel": "Diluted loss per share from continuing operations, attributable to equity holders of the Company", "totalLabel": "Total diluted earnings (loss) per share" } }, "en": { "role": { "documentation": "Diluted earnings (loss) per share from continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Diluted earnings (loss) per share]" } } }, "auth_ref": [ "r16", "r17" ] }, "ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DilutedEarningsLossPerShareFromDiscontinuedOperations", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss" ], "lang": { "en-us": { "role": { "label": "Diluted loss per share from discontinued operations, attributable to equity holders of the Company" } }, "en": { "role": { "documentation": "Diluted earnings (loss) per share from discontinued operations. [Refer: Diluted earnings (loss) per share; Discontinued operations [member]]" } } }, "auth_ref": [ "r17", "r18" ] }, "evgn_DisclosureOfAssetsClassifiedAsHeldForSaleExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "DisclosureOfAssetsClassifiedAsHeldForSaleExplanatory", "presentation": [ "http://www.evogene.com/role/ASSETSHELDFORSALEANDDISCONTINUEDOPERATIONSTables" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for assets classified as held for sale.", "label": "Disclosure Of Assets Classified As Held For Sale Explanatory", "terseLabel": "Schedule of assets classified as held for sale" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfBusinessCombinationsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfBusinessCombinationsLineItems", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about business combination [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfBusinessCombinationsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfBusinessCombinationsTable", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about business combination [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of business combinations." } } }, "auth_ref": [ "r81", "r144" ] }, "ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfChangesInAccountingPoliciesExplanatory", "presentation": [ "http://www.evogene.com/role/SignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Changes in accounting policies", "terseLabel": "SIGNIFICANT ACCOUNTING POLICIES" } }, "en": { "role": { "documentation": "The disclosure of changes made to accounting policies by the entity." } } }, "auth_ref": [ "r320" ] }, "evgn_DisclosureOfDetailedInformationAboutLiabilitiesInRespectOfGovernmentGrantsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "DisclosureOfDetailedInformationAboutLiabilitiesInRespectOfGovernmentGrantsExplanatory", "presentation": [ "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about liabilities in respect of Government grants.", "label": "Disclosure Of Detailed Information About Liabilities In Respect Of Government Grants Explanatory", "verboseLabel": "Schedule of Liabilities in Respect of Government Grants" } } }, "auth_ref": [] }, "evgn_DisclosureOfDetailedInformationAboutOtherRecevablesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "DisclosureOfDetailedInformationAboutOtherRecevablesExplanatory", "presentation": [ "http://www.evogene.com/role/OtherReceivablesAndPrepaidExpensesTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about other recevables and prepaid expenses.", "label": "Disclosure Of Detailed Information About Other Recevables Explanatory", "verboseLabel": "Schedule of Other Receivables and Prepaid Expenses" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsScheduleOfPercentageOfNon-currentAssetsDetails", "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesAndOperatingLossBySegmentsDetails", "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesBasedOnCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of disaggregation of revenue from contracts with customers [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsScheduleOfPercentageOfNon-currentAssetsDetails", "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesAndOperatingLossBySegmentsDetails", "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesBasedOnCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of disaggregation of revenue from contracts with customers [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the disaggregation of revenue from contracts with customers." } } }, "auth_ref": [ "r57", "r111" ] }, "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfEntitysReportableSegmentsExplanatory", "presentation": [ "http://www.evogene.com/role/OperatingSegments" ], "lang": { "en-us": { "role": { "label": "OPERATING SEGMENTS" } }, "en": { "role": { "documentation": "The entire disclosure for operating segments." } } }, "auth_ref": [ "r110" ] }, "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory", "presentation": [ "http://www.evogene.com/role/SUBSEQUENTEVENTS" ], "lang": { "en-us": { "role": { "label": "Disclosure of events after reporting period [text block]", "verboseLabel": "SUBSEQUENT EVENTS" } }, "en": { "role": { "documentation": "The entire disclosure for events after the reporting period." } } }, "auth_ref": [ "r1" ] }, "ifrs-full_DisclosureOfFinancialInstrumentsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfFinancialInstrumentsAbstract", "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about financial instruments [abstract]" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfFinancialInstrumentsExplanatory", "presentation": [ "http://www.evogene.com/role/FinancialInstruments" ], "lang": { "en-us": { "role": { "label": "FINANCIAL INSTRUMENTS" } }, "en": { "role": { "documentation": "The entire disclosure for financial instruments." } } }, "auth_ref": [ "r94" ] }, "ifrs-full_DisclosureOfFinancialInstrumentsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfFinancialInstrumentsLineItems", "presentation": [ "http://www.evogene.com/role/FINANCIALINSTRUMENTSScheduleOfFairValueOfFinancialLiabilitiesDetails", "http://www.evogene.com/role/FinancialInstrumentsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about financial instruments [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFinancialInstrumentsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfFinancialInstrumentsTable", "presentation": [ "http://www.evogene.com/role/FINANCIALINSTRUMENTSScheduleOfFairValueOfFinancialLiabilitiesDetails", "http://www.evogene.com/role/FinancialInstrumentsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about financial instruments [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of financial instruments." } } }, "auth_ref": [ "r88", "r90", "r93", "r145" ] }, "ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfFinancialLiabilitiesExplanatory", "presentation": [ "http://www.evogene.com/role/FinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial liabilities [text block]", "terseLabel": "Schedule Of Financial Liabilities" } }, "en": { "role": { "documentation": "The disclosure of financial liabilities. [Refer: Financial liabilities]" } } }, "auth_ref": [ "r93", "r145" ] }, "ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "presentation": [ "http://www.evogene.com/role/General" ], "lang": { "en-us": { "role": { "label": "GENERAL" } }, "en": { "role": { "documentation": "The entire disclosure for general information about financial statements." } } }, "auth_ref": [ "r114", "r164" ] }, "evgn_DisclosureOfGeneralInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "DisclosureOfGeneralInformationAbstract", "lang": { "en-us": { "role": { "label": "Disclosure Of General Information [Abstract]", "verboseLabel": "Disclosure of general [Abstract]" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfGeographicalAreasExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfGeographicalAreasExplanatory", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Geographical Information" } }, "en": { "role": { "documentation": "The disclosure of geographical information." } } }, "auth_ref": [ "r108" ] }, "ifrs-full_DisclosureOfGovernmentGrantsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfGovernmentGrantsExplanatory", "presentation": [ "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrants" ], "lang": { "en-us": { "role": { "label": "LIABILITIES IN RESPECT OF GOVERNMENT GRANTS" } }, "en": { "role": { "documentation": "The entire disclosure for government grants." } } }, "auth_ref": [ "r8" ] }, "ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Assumptions Used to Value Options" } }, "en": { "role": { "documentation": "The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options." } } }, "auth_ref": [ "r77" ] }, "evgn_DisclosureOfLiabilitiesInRespectOfGovernmentGrantAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "DisclosureOfLiabilitiesInRespectOfGovernmentGrantAbstract", "lang": { "en-us": { "role": { "documentation": "Disclosure of Liabilities in Respect of Government Grant [Abstract]", "label": "Disclosure Of Liabilities In Respect Of Government Grant [Abstract]", "terseLabel": "Liabilities In Respect Of Government Grants Schedule Of Liabilities In Respect Of Government Grants", "verboseLabel": "Liabilities In Respect Of Government Grants" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfMajorCustomersLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfMajorCustomersLineItems", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesFromMajorCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of major customers [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfMajorCustomersTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfMajorCustomersTable", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesFromMajorCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of major customers [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the entity's major customers." } } }, "auth_ref": [ "r109" ] }, "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract", "lang": { "en-us": { "role": { "label": "Disclosure of non-adjusting events after reporting period [abstract]" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems", "presentation": [ "http://www.evogene.com/role/SUBSEQUENTEVENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of non-adjusting events after reporting period [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodTable", "presentation": [ "http://www.evogene.com/role/SUBSEQUENTEVENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of non-adjusting events after reporting period [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to non-adjusting events after the reporting period." } } }, "auth_ref": [ "r0", "r124" ] }, "ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory", "presentation": [ "http://www.evogene.com/role/ASSETSHELDFORSALEANDDISCONTINUEDOPERATIONS" ], "lang": { "en-us": { "role": { "label": "Disclosure of non-current assets held for sale and discontinued operations [text block]", "terseLabel": "DISCONTINUED OPERATIONS", "verboseLabel": "Schedule of Percentage of Non-Current Assets" } }, "en": { "role": { "documentation": "The entire disclosure for non-current assets held for sale and discontinued operations." } } }, "auth_ref": [ "r86" ] }, "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of number and weighted average exercise prices of other equity instruments [text block]", "verboseLabel": "Schedule of Number of Restricted Stock Units (RSU)" } }, "en": { "role": { "documentation": "The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options)." } } }, "auth_ref": [ "r317" ] }, "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Number of Share Options" } }, "en": { "role": { "documentation": "The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r72", "r141" ] }, "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Share Options Outstanding" } }, "en": { "role": { "documentation": "The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r74" ] }, "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfShareOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfShareOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the number and weighted average remaining contractual life of outstanding share options." } } }, "auth_ref": [ "r74" ] }, "evgn_DisclosureOfOperatingResultsAttributedToDiscontinuedOperationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "DisclosureOfOperatingResultsAttributedToDiscontinuedOperationExplanatory", "presentation": [ "http://www.evogene.com/role/ASSETSHELDFORSALEANDDISCONTINUEDOPERATIONSTables" ], "lang": { "en-us": { "role": { "documentation": "Disclosure Of Operating Results Attributed To Discontinued Operation Explanatory", "label": "Disclosure Of Operating Results Attributed To Discontinued Operation Explanatory", "verboseLabel": "Schedule of operating results attributed to discontinued operation" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfOperatingSegmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfOperatingSegmentsAbstract", "lang": { "en-us": { "role": { "label": "Disclosure of operating segments [Abstract]" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfOperatingSegmentsExplanatory", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Revenues and Operating Loss by Segments" } }, "en": { "role": { "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]" } } }, "auth_ref": [ "r98" ] }, "ifrs-full_DisclosureOfOperatingSegmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfOperatingSegmentsLineItems", "presentation": [ "http://www.evogene.com/role/OPERATINGSEGMENTSDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of operating segments [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfOperatingSegmentsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfOperatingSegmentsTable", "presentation": [ "http://www.evogene.com/role/OPERATINGSEGMENTSDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of operating segments [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to operating segments." } } }, "auth_ref": [ "r98" ] }, "evgn_DisclosureOfOtherAccountsReceivablesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "DisclosureOfOtherAccountsReceivablesAbstract", "lang": { "en-us": { "role": { "documentation": "Disclosure of other receivables [Abstract]", "label": "Disclosure Of Other Accounts Receivables [Abstract]", "terseLabel": "Other Receivables And Prepaid Expenses Schedule Of Other Receivables And Prepaid Expenses", "verboseLabel": "Other Receivables And Prepaid Expenses" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfOtherNoncurrentAssetsExplanatory", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of other non-current assets [text block]", "terseLabel": "ASSETS HELD FOR SALE AND DISCONTINUED OPERATIONS", "verboseLabel": "Schedule of Percentage of Non-Current Assets" } }, "en": { "role": { "documentation": "The disclosure of other non-current assets. [Refer: Other non-current assets]" } } }, "auth_ref": [ "r320" ] }, "evgn_DisclosureOfRevenueFromContractsWithCustomersAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "DisclosureOfRevenueFromContractsWithCustomersAbstract", "lang": { "en-us": { "role": { "documentation": "Disclosure of collaboration agreement [Abstract]", "label": "Disclosure Of Revenue From Contracts With Customers [Abstract]", "terseLabel": "Disclosure of revenue from contracts with customers [Abstract]" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfRevenueFromContractsWithCustomersExplanatory", "presentation": [ "http://www.evogene.com/role/REVENUEFROMCONTRACTSWITHCUSTOMERS" ], "lang": { "en-us": { "role": { "label": "Disclosure of revenue from contracts with customers [text block]", "terseLabel": "REVENUE FROM CONTRACTS WITH CUSTOMERS" } }, "en": { "role": { "documentation": "The entire disclosure for revenue from contracts with customers." } } }, "auth_ref": [ "r59", "r60" ] }, "ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfSegmentsMajorCustomersExplanatory", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Major Customers" } }, "en": { "role": { "documentation": "The disclosure of major customers." } } }, "auth_ref": [ "r109" ] }, "ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfSharebasedPaymentArrangementsExplanatory", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensation" ], "lang": { "en-us": { "role": { "label": "SHARE- BASED COMPENSATION", "terseLabel": "SHARE-BASED COMPENSATION" } }, "en": { "role": { "documentation": "The entire disclosure for share-based payment arrangements." } } }, "auth_ref": [ "r65" ] }, "evgn_DisclosureOfSignificantAccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "DisclosureOfSignificantAccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Disclosure Of Significant Accounting Policies [Abstract]", "verboseLabel": "Disclosure of significant accounting policies [Abstract]" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract", "lang": { "en-us": { "role": { "label": "Disclosure of terms and conditions of share-based payment arrangement [abstract]" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems", "presentation": [ "http://www.evogene.com/role/SHAREBASEDCOMPENSATIONScheduleOfRestrictedStockUnitsActivityDetails", "http://www.evogene.com/role/Share-BasedCompensationNarrativeDetails", "http://www.evogene.com/role/Share-BasedCompensationScheduleOfAssumptionsUsedToValueOptionsDetails", "http://www.evogene.com/role/Share-BasedCompensationScheduleOfSummarizedNumberOfShareOptionsDetails", "http://www.evogene.com/role/Share-BasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of terms and conditions of share-based payment arrangement [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable", "presentation": [ "http://www.evogene.com/role/SHAREBASEDCOMPENSATIONScheduleOfRestrictedStockUnitsActivityDetails", "http://www.evogene.com/role/Share-BasedCompensationNarrativeDetails", "http://www.evogene.com/role/Share-BasedCompensationScheduleOfAssumptionsUsedToValueOptionsDetails", "http://www.evogene.com/role/Share-BasedCompensationScheduleOfSummarizedNumberOfShareOptionsDetails", "http://www.evogene.com/role/Share-BasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of terms and conditions of share-based payment arrangement [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to terms and conditions of share-based payment arrangements." } } }, "auth_ref": [ "r75", "r142" ] }, "ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfTradeAndOtherReceivablesExplanatory", "presentation": [ "http://www.evogene.com/role/OtherReceivablesAndPrepaidExpenses" ], "lang": { "en-us": { "role": { "label": "OTHER RECEIVABLES AND PREPAID EXPENSES" } }, "en": { "role": { "documentation": "The disclosure of trade and other receivables. [Refer: Trade and other receivables]" } } }, "auth_ref": [ "r320" ] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesLineItems", "presentation": [ "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of transactions between related parties [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable", "presentation": [ "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of transactions between related parties [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to transactions between related parties." } } }, "auth_ref": [ "r9", "r129" ] }, "evgn_DisclosureofDetailedInformationAboutofRevenuesByTimingOfRevenueRecognitionExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "DisclosureofDetailedInformationAboutofRevenuesByTimingOfRevenueRecognitionExplanatory", "presentation": [ "http://www.evogene.com/role/REVENUEFROMCONTRACTSWITHCUSTOMERSTables" ], "lang": { "en-us": { "role": { "documentation": "Disclosure Of Detailed Information About Of revenues by timing of revenue recognition Explanatory.", "label": "Disclosureof Detailed Information Aboutof Revenues By Timing Of Revenue Recognition Explanatory", "terseLabel": "Schedule of revenues by timing of revenue recognition" } } }, "auth_ref": [] }, "ifrs-full_DiscontinuedOperationsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DiscontinuedOperationsMember", "presentation": [ "http://www.evogene.com/role/ASSETSHELDFORSALEANDDISCONTINUEDOPERATIONSDetails1" ], "lang": { "en-us": { "role": { "label": "Discontinued operations [member]" } }, "en": { "role": { "documentation": "This member stands for a component of an entity that either has been disposed of or is classified as held for sale, and that: (a) represents a separate major line of business or geographical area of operations; (b) is part of a single co-ordinated plan to dispose of a separate major line of business or geographical area of operations; or (c) is a subsidiary acquired exclusively with a view to resale. A component of an entity comprises operations and cash flows that can be clearly distinguished, operationally and for financial reporting purposes, from the rest of the entity. [Refer: Total for all subsidiaries [member]]" } } }, "auth_ref": [ "r86" ] }, "ifrs-full_DividendsPaid": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DividendsPaid", "crdr": "debit", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Dividends recognised as distributions to owners", "terseLabel": "Dividend distributed to shareholders" } }, "en": { "role": { "documentation": "The amount of dividends recognised as distributions to owners." } } }, "auth_ref": [ "r115", "r156", "r163" ] }, "ifrs-full_DividendsPaidToNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DividendsPaidToNoncontrollingInterests", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Dividends paid to non-controlling interests" } }, "en": { "role": { "documentation": "The amount of dividends paid to non-controlling interests. [Refer: Non-controlling interests]" } } }, "auth_ref": [ "r40" ] }, "ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "weight": -1.0, "order": 20.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividend paid by subsidiary to non-controlling interests", "label": "Dividends paid to non-controlling interests, classified as financing activities" } }, "en": { "role": { "documentation": "The cash outflow for dividends paid to non-controlling interests, classified as financing activities. [Refer: Non-controlling interests; Dividends paid to non-controlling interests]" } } }, "auth_ref": [ "r312" ] }, "ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DividendsRecognisedAsDistributionsToNoncontrollingInterests", "crdr": "debit", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividend to non-controlling interests", "label": "Dividends recognised as distributions to non-controlling interests", "verboseLabel": "Dividend to non-controlling interests" } }, "en": { "role": { "documentation": "The amount of dividends recognised as distributions to non-controlling interests. [Refer: Non-controlling interests]" } } }, "auth_ref": [ "r321" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentAccountingStandard", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r224" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentAnnualReport", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r223", "r224", "r236" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r223", "r224", "r236", "r279" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentRegistrationStatement", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r219" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentShellCompanyReport", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r224" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentTransitionReport", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r257" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentType", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]", "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year" } } }, "auth_ref": [ "r268" ] }, "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Exchange rate differences on cash and cash equivalent balances", "terseLabel": "Exchange rate differences - cash and cash equivalent balances" } }, "en": { "role": { "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r24", "r25" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Employee Stock Option [Member]", "terseLabel": "Employee Stock Option" } } }, "auth_ref": [] }, "evgn_EmployeesAndConsultantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "EmployeesAndConsultantsMember", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Employees and consultants {Member]", "label": "Employees And Consultants [Member]", "verboseLabel": "Employees, Directors and Consultants [Member]" } } }, "auth_ref": [] }, "evgn_EmployeesConsultantsDirectorsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "EmployeesConsultantsDirectorsMember", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfSummarizedNumberOfShareOptionsDetails", "http://www.evogene.com/role/Share-BasedCompensationTables" ], "lang": { "en-us": { "role": { "documentation": "Employees Consultants and Directors [Member]", "label": "Employees Consultants Directors Member", "verboseLabel": "Employees Consultants and Directors [Member]" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine3", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressCountry", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressesAddressTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressesAddressTypeAxis", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Addresses, Address Type [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_EntityAddressesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressesLineItems", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Addresses [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityAddressesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressesTable", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Addresses [Table]", "documentation": "Container of address information for the entity" } } }, "auth_ref": [ "r221" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r221" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity's Reporting Status Current", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r221" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFileNumber", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFilerCategory", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r221" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r308" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityRegistrantName", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r221" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityShellCompany", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r221" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityVoluntaryFilers", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity a Voluntary Filer", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity a Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r309" ] }, "ecd_EqtyAwrdsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Awards Adjustments, Footnote [Text Block]", "terseLabel": "Equity Awards Adjustments, Footnote" } } }, "auth_ref": [ "r262" ] }, "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]", "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table" } } }, "auth_ref": [ "r304" ] }, "ecd_EqtyAwrdsAdjsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsAdjsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Awards Adjustments [Member]", "terseLabel": "Equity Awards Adjustments" } } }, "auth_ref": [ "r304" ] }, "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]", "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table" } } }, "auth_ref": [ "r304" ] }, "ifrs-full_Equity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Equity", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfChangesInEquity", "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "periodEndLabel": "Balance", "periodStartLabel": "Balance", "label": "Equity", "totalLabel": "TOTAL EQUITY" } }, "en": { "role": { "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities." } } }, "auth_ref": [ "r32", "r34", "r52", "r53", "r54", "r130", "r133", "r150", "r151", "r158", "r172", "r176" ] }, "ifrs-full_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EquityAbstract", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "SHAREHOLDERS' EQUITY:" } } }, "auth_ref": [] }, "ifrs-full_EquityAndLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EquityAndLiabilities", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Equity and liabilities", "totalLabel": "TOTAL LIABILITIES AND EQUITY" } }, "en": { "role": { "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]" } } }, "auth_ref": [ "r172" ] }, "ifrs-full_EquityAndLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EquityAndLiabilitiesAbstract", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Equity and liabilities [abstract]", "terseLabel": "LIABILITIES AND EQUITY" } } }, "auth_ref": [] }, "ifrs-full_EquityAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EquityAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "periodEndLabel": "Balance", "periodStartLabel": "Balance", "label": "Equity attributable to owners of parent", "totalLabel": "Equity attributable to equity holders of the Company" } }, "en": { "role": { "documentation": "The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest." } } }, "auth_ref": [ "r171" ] }, "ifrs-full_EquityAttributableToOwnersOfParentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EquityAttributableToOwnersOfParentMember", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Total equity", "terseLabel": "Total" } }, "en": { "role": { "documentation": "This member stands for equity attributable to the owners of the parent." } } }, "auth_ref": [ "r162" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]", "terseLabel": "Equity Valuation Assumption Difference, Footnote" } } }, "auth_ref": [ "r272" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]", "terseLabel": "Erroneous Compensation Analysis" } } }, "auth_ref": [ "r229", "r240", "r250", "r283" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]", "terseLabel": "Erroneously Awarded Compensation Recovery" } } }, "auth_ref": [ "r226", "r237", "r247", "r280" ] }, "srt_EuropeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "EuropeMember", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesBasedOnCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Europe [Member]" } } }, "auth_ref": [] }, "evgn_EvogenesMicroboostAiTechengineMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "EvogenesMicroboostAiTechengineMember", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represent the member of Evogene\u2019s MicroBoost AI Tech-Engine", "label": "Evogene\u2019s Microboost Ai Tech-engine [Member]" } } }, "auth_ref": [] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]", "terseLabel": "Executive Category:" } } }, "auth_ref": [ "r278" ] }, "evgn_ExerciseOfExistingWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ExerciseOfExistingWarrants", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/FINANCIALINSTRUMENTSScheduleOfFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "It represents as a exercise of existing warrants.", "label": "Exercise Of Existing Warrants" } } }, "auth_ref": [] }, "evgn_ExerciseOfOptionsParValue": { "xbrltype": "perShareItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ExerciseOfOptionsParValue", "presentation": [ "http://www.evogene.com/role/SUBSEQUENTEVENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "The number of share options par value in a share-based payment arrangement.", "label": "Exercise Of Options Par Value", "terseLabel": "Exercise of options par value", "verboseLabel": "Exercise of options and vesting of restricted share units (\u201cRSUs\u201d)" } } }, "auth_ref": [] }, "evgn_ExerciseOfPreFundedWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ExerciseOfPreFundedWarrants", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows", "http://www.evogene.com/role/FINANCIALINSTRUMENTSScheduleOfFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of exercise of pre-funded warrants.", "label": "Exercise Of Pre Funded Warrants", "terseLabel": "Exercise of pre-funded warrants", "verboseLabel": "Exercise of pre-funded warrants" } } }, "auth_ref": [] }, "evgn_ExerciseOfSubsidiaryOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ExerciseOfSubsidiaryOptions", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "documentation": "Exercise of subsidiary options.", "label": "Exercise Of Subsidiary Options", "verboseLabel": "Exercise of subsidiary options" } } }, "auth_ref": [] }, "evgn_ExercisePriceRangeFourMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ExercisePriceRangeFourMember", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfShareOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "documentation": "Over 40.00 [Member]", "label": "Exercise Price Range Four [Member]", "verboseLabel": "103.40 \u2013 108.60 [Member]" } } }, "auth_ref": [] }, "evgn_ExercisePriceRangeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ExercisePriceRangeMember", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfShareOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "documentation": "Up to 10.00 [Member]", "label": "Exercise Price Range [Member]", "verboseLabel": "2.36 - 10 [Member]" } } }, "auth_ref": [] }, "evgn_ExercisePriceRangeNetMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ExercisePriceRangeNetMember", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfShareOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "documentation": "Exercise price range [Member]", "label": "Exercise Price Range Net Member" } } }, "auth_ref": [] }, "evgn_ExercisePriceRangeOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ExercisePriceRangeOneMember", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfShareOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "documentation": "10.01-20.00 [Member]", "label": "Exercise Price Range One [Member]", "verboseLabel": "10.20 - 20 [Member]" } } }, "auth_ref": [] }, "evgn_ExercisePriceRangeThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ExercisePriceRangeThreeMember", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfShareOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "documentation": "30.01-40.00 [Member]", "label": "Exercise Price Range Three [Member]", "verboseLabel": "48.80 \u2013 76.19 [Member]" } } }, "auth_ref": [] }, "evgn_ExercisePriceRangeTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ExercisePriceRangeTwoMember", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfShareOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "documentation": "20.01-30.00 [Member]", "label": "Exercise Price Range Two [Member]", "verboseLabel": "22.26 - 40.22 [Member]" } } }, "auth_ref": [] }, "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ExpectedDividendAsPercentageShareOptionsGranted", "presentation": [ "http://www.evogene.com/role/FinancialInstrumentsNarrativeDetails", "http://www.evogene.com/role/Share-BasedCompensationScheduleOfAssumptionsUsedToValueOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Dividend yield (%)", "terseLabel": "Dividend yield" } }, "en": { "role": { "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted." } } }, "auth_ref": [ "r76" ] }, "ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets", "crdr": "debit", "calculation": { "http://www.evogene.com/role/Share-BasedCompensationScheduleOfCompensationCostOfEquity-basedAwardsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfCompensationCostOfEquity-basedAwardsDetails" ], "lang": { "en-us": { "role": { "label": "Expense from share-based payment transactions in which goods or services received did not qualify for recognition as assets", "totalLabel": "Total share-based compensation" } } }, "auth_ref": [ "r80", "r143" ] }, "evgn_ExpensesRelatedToWarrantsInducementTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ExpensesRelatedToWarrantsInducementTransaction", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": 1.0, "order": 110.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Represent the amount of Expenses related to warrants inducement transaction", "label": "Expenses Related To Warrants Inducement Transaction", "verboseLabel": "Expenses related to warrants inducement transaction" } } }, "auth_ref": [] }, "ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Expense Recognized in Financial Statements" } }, "en": { "role": { "documentation": "The explanation that enables users of financial statements to understand the effect of share-based payment transactions on the entity's financial position." } } }, "auth_ref": [ "r79" ] }, "ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Explanation of effect of share-based payments on entity's profit or loss [text block]", "verboseLabel": "Schedule of Compensation Cost of Equity-Based Awards" } }, "en": { "role": { "documentation": "The explanation that enables users of financial statements to understand the effect of share-based payment transactions on the entity's profit (loss)." } } }, "auth_ref": [ "r79" ] }, "evgn_FairValueOfOptionsGranted": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "FairValueOfOptionsGranted", "crdr": "debit", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represent the fair value of options granted.", "label": "Fair Value Of Options Granted", "terseLabel": "Fair value of options granted" } } }, "auth_ref": [] }, "evgn_FairValueOfRestrictedShareUnitsGranted": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "FairValueOfRestrictedShareUnitsGranted", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Fair value of Restricted Share Units granted.", "label": "Fair Value Of Restricted Share Units Granted", "terseLabel": "Fair value of Restricted Share Units granted" } } }, "auth_ref": [] }, "evgn_FairValueOfSubsidiariesOptionsGranted": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "FairValueOfSubsidiariesOptionsGranted", "crdr": "debit", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Fair value of subsidiaries options granted.", "label": "Fair Value Of Subsidiaries Options Granted", "verboseLabel": "Fair value of subsidiaries options granted" } } }, "auth_ref": [] }, "ifrs-full_FinanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "FinanceCosts", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss": { "parentTag": "evgn_FinanceIncomeExpensesNet", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/ASSETSHELDFORSALEANDDISCONTINUEDOPERATIONSDetails1", "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss", "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Financing expenses", "negatedTerseLabel": "Finance expenses", "label": "Finance costs" } } }, "auth_ref": [ "r185" ] }, "ifrs-full_FinanceIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "FinanceIncome", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss": { "parentTag": "evgn_FinanceIncomeExpensesNet", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss", "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Financing income", "label": "Finance income", "terseLabel": "Financing income", "totalLabel": "Financing income", "verboseLabel": "Financing income" } } }, "auth_ref": [ "r325" ] }, "evgn_FinanceIncomeExpensesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "FinanceIncomeExpensesNet", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss" ], "lang": { "en-us": { "role": { "documentation": "Finance Income Expense Net.", "label": "Finance Income Expenses Net", "totalLabel": "Financing income (loss), net" } } }, "auth_ref": [] }, "ifrs-full_FinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "FinancialLiabilities", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/FINANCIALINSTRUMENTSScheduleOfFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Financial liabilities at end of period", "periodStartLabel": "Financial liabilities at beginning of period", "label": "Financial liabilities", "totalLabel": "Total Financial Liabilities", "verboseLabel": "Financial liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Classes of financial instruments [domain]; Financial assets; Derivatives [member]]" } } }, "auth_ref": [ "r87" ] }, "evgn_FinancingIncomeExpensesBySegment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "FinancingIncomeExpensesBySegment", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesAndOperatingLossBySegmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of financing income (expenses) by operating segment.", "label": "Financing Income Expenses By Segment", "terseLabel": "Net financing income (expenses)" } } }, "auth_ref": [] }, "evgn_ForfeitureOfNonControllingInterestsRegardingShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ForfeitureOfNonControllingInterestsRegardingShareBasedCompensation", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "documentation": "Represents amount of forfeiture of non-controlling interests regarding share based compensation.", "negatedLabel": "Forfeiture of non-controlling interests regarding share-based compensation", "label": "Forfeiture Of Non Controlling Interests Regarding Share Based Compensation", "terseLabel": "Forfeiture of non-controlling interests regarding share-based compensation" } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r233", "r244", "r254", "r287" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount", "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r233", "r244", "r254", "r287" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount", "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r233", "r244", "r254", "r287" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]", "terseLabel": "Forgone Recovery, Explanation of Impracticability" } } }, "auth_ref": [ "r233", "r244", "r254", "r287" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r233", "r244", "r254", "r287" ] }, "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]", "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year" } } }, "auth_ref": [ "r267" ] }, "evgn_GeneralAndAdministrativeExpenseSharesBasedArrangement": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "GeneralAndAdministrativeExpenseSharesBasedArrangement", "crdr": "debit", "calculation": { "http://www.evogene.com/role/Share-BasedCompensationScheduleOfCompensationCostOfEquity-basedAwardsDetails": { "parentTag": "ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfCompensationCostOfEquity-basedAwardsDetails" ], "lang": { "en-us": { "role": { "documentation": "General and administrative expenses related with share based compensation.", "label": "General And Administrative Expense Shares Based Arrangement", "verboseLabel": "General and administrative" } } }, "auth_ref": [] }, "ifrs-full_GeographicalAreasAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GeographicalAreasAxis", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsScheduleOfPercentageOfNon-currentAssetsDetails", "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesBasedOnCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Geographical areas [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r108", "r192", "r202", "r204", "r208" ] }, "ifrs-full_GeographicalAreasDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GeographicalAreasDomain", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsScheduleOfPercentageOfNon-currentAssetsDetails", "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesBasedOnCustomersDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used." } } }, "auth_ref": [ "r108", "r192", "r202", "r204", "r208" ] }, "evgn_GovernmentAuthoritiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "GovernmentAuthoritiesCurrent", "crdr": "debit", "calculation": { "http://www.evogene.com/role/OtherReceivablesAndPrepaidExpensesScheduleOfOtherReceivablesAndPrepaidExpensesDetails": { "parentTag": "ifrs-full_OtherCurrentReceivables", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.evogene.com/role/OtherReceivablesAndPrepaidExpensesScheduleOfOtherReceivablesAndPrepaidExpensesDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount represent receivables from current governmental units.", "label": "Government Authorities Current", "verboseLabel": "Government authorities" } } }, "auth_ref": [] }, "evgn_GovernmentGrant": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "GovernmentGrant", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsScheduleOfLiabilitiesInRespectOfGovernmentGrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of assistance by government in the form of transfers of resources to an entity in return for past or future compliance with certain conditions relating to the operating activities of the entity, recognised as deferred income. They exclude those forms of government assistance that cannot reasonably have a value placed upon them and transactions with government that cannot be distinguished from the normal trading transactions of the entity.", "periodEndLabel": "Balance on December 31,", "periodStartLabel": "Balance on January 1,", "label": "Government Grant" } } }, "auth_ref": [] }, "evgn_GrantReceivablesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "GrantReceivablesCurrent", "crdr": "debit", "calculation": { "http://www.evogene.com/role/OtherReceivablesAndPrepaidExpensesScheduleOfOtherReceivablesAndPrepaidExpensesDetails": { "parentTag": "ifrs-full_OtherCurrentReceivables", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/OtherReceivablesAndPrepaidExpensesScheduleOfOtherReceivablesAndPrepaidExpensesDetails" ], "lang": { "en-us": { "role": { "documentation": "Grant receivables current.", "label": "Grant Receivables Current", "verboseLabel": "Grant receivables" } } }, "auth_ref": [] }, "evgn_GrantsReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "GrantsReceived", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsScheduleOfLiabilitiesInRespectOfGovernmentGrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of cash received in relation to royalty-bearing R and D government grants.", "label": "Grants received", "verboseLabel": "Grants received" } } }, "auth_ref": [] }, "evgn_GrantsToBeReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "GrantsToBeReceived", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsScheduleOfLiabilitiesInRespectOfGovernmentGrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of grants to be received.", "label": "Grants To Be Received", "verboseLabel": "Grants to be received" } } }, "auth_ref": [] }, "ifrs-full_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.evogene.com/role/ASSETSHELDFORSALEANDDISCONTINUEDOPERATIONSDetails1", "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss" ], "lang": { "en-us": { "role": { "label": "Gross profit", "totalLabel": "Gross profit" } } }, "auth_ref": [ "r213" ] }, "evgn_HumanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "HumanMember", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesAndOperatingLossBySegmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Human [Member]", "label": "Human [Member]", "terseLabel": "Human health [Member]" } } }, "auth_ref": [] }, "country_IL": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2025", "localname": "IL", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsScheduleOfPercentageOfNon-currentAssetsDetails", "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesBasedOnCustomersDetails" ], "lang": { "en-us": { "role": { "label": "ISRAEL", "verboseLabel": "Israel [Member]" } } }, "auth_ref": [] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r223", "r224", "r236" ] }, "evgn_IclGroupMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "IclGroupMember", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "It represents Icl Group.", "label": "Icl Group [Member]", "terseLabel": "ICL Group [Member]", "verboseLabel": "ICL Group" } } }, "auth_ref": [] }, "ifrs-full_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Profit or loss [abstract]" } } }, "auth_ref": [] }, "ifrs-full_IncomeTaxExpenseContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncomeTaxExpenseContinuingOperations", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss": { "parentTag": "ifrs-full_ProfitLossFromContinuingOperations", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://www.evogene.com/role/ASSETSHELDFORSALEANDDISCONTINUEDOPERATIONSDetails1", "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss" ], "lang": { "en-us": { "role": { "label": "Tax expense (income)", "verboseLabel": "Taxes on income" } } }, "auth_ref": [ "r2", "r3", "r4", "r10", "r49", "r97", "r125", "r126", "r127", "r187" ] }, "ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncomeTaxesPaidClassifiedAsOperatingActivities", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 20.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Taxes paid", "label": "Income taxes paid, classified as operating activities" } }, "en": { "role": { "documentation": "The cash outflow for income taxes paid, classified as operating activities." } } }, "auth_ref": [ "r316" ] }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseInCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) in cash and cash equivalents", "totalLabel": "Decrease in cash and cash equivalents" } }, "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]" } } }, "auth_ref": [ "r30", "r123" ] }, "evgn_IncreaseDecreaseInEquityResultingFromShareBasedPaymentTransactionsAndRestrictedStockUnit": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "IncreaseDecreaseInEquityResultingFromShareBasedPaymentTransactionsAndRestrictedStockUnit", "crdr": "debit", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "documentation": "Represents amount of increase (decrease) in equity resulting from share-based payment transactions and RSUs.", "label": "Increase Decrease In Equity Resulting From Share Based Payment Transactions And Restricted Stock Unit", "terseLabel": "Share-based compensation and RSUs" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseThroughExerciseOfOptions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughExerciseOfOptions", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Exercise of options" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from the exercise of options." } } }, "auth_ref": [ "r321" ] }, "evgn_IncreaseDecreaseThroughExerciseOfPrefundedWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "IncreaseDecreaseThroughExerciseOfPrefundedWarrants", "crdr": "debit", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "documentation": "Represent the amount of Exercise of pre-funded warrants", "label": "Increase Decrease Through Exercise Of Pre-funded Warrants", "terseLabel": "Exercise of pre-funded warrants" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughExerciseOfWarrantsEquity", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) through exercise of warrants, equity", "terseLabel": "Exercise of warrants" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from the exercise of warrants." } } }, "auth_ref": [ "r321" ] }, "evgn_IncreaseDecreaseThroughShareBasedPaymentTransactionsEquityHoldersOfCompany": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "IncreaseDecreaseThroughShareBasedPaymentTransactionsEquityHoldersOfCompany", "crdr": "debit", "calculation": { "http://www.evogene.com/role/Share-BasedCompensationScheduleOfCompanysFinancialStatementsDetails": { "parentTag": "evgn_AdjustmentsForShareBasedPaymentsExpenseRecognizedForServicesProvidedByEmployees", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfCompanysFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for share-based payments from equity holders of the Company to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Increase Decrease Through Share Based Payment Transactions Equity Holders Of Company", "verboseLabel": "Share-based compensation \u2013 Attributable to equity holders of the Company" } } }, "auth_ref": [] }, "evgn_IncreaseDecreaseThroughShareBasedPaymentTransactionsNonControllingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "IncreaseDecreaseThroughShareBasedPaymentTransactionsNonControllingInterest", "crdr": "debit", "calculation": { "http://www.evogene.com/role/Share-BasedCompensationScheduleOfCompanysFinancialStatementsDetails": { "parentTag": "evgn_AdjustmentsForShareBasedPaymentsExpenseRecognizedForServicesProvidedByEmployees", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfCompanysFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for share-based payments from non-controlling interests to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Increase Decrease Through Share Based Payment Transactions Non Controlling Interest", "terseLabel": "Share-based compensation \u2013 Attributable to non-controlling interests" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Share-based compensation" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]" } } }, "auth_ref": [ "r161" ] }, "evgn_IncreaseOfOperatingLeaseRightofuseassets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "IncreaseOfOperatingLeaseRightofuseassets", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Increase of operating lease right-of-use-assets.", "label": "Increase Of Operating Lease Rightofuseassets", "verboseLabel": "Right-of-use assets recognized with corresponding lease liability" } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]", "terseLabel": "Individual:" } } }, "auth_ref": [ "r233", "r244", "r254", "r278", "r287", "r291", "r299" ] }, "evgn_InducementLetterAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "InducementLetterAgreementMember", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Inducement Letter Agreement [Member]" } } }, "auth_ref": [] }, "evgn_IndustryMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "IndustryMember", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesAndOperatingLossBySegmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Industry [Member]", "label": "Industry [Member]", "terseLabel": "Industrial application [Member]" } } }, "auth_ref": [] }, "evgn_InitialRecognitionOfNewWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "InitialRecognitionOfNewWarrants", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/FINANCIALINSTRUMENTSScheduleOfFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "It represents as a initial recognition of New Warrants.", "label": "Initial Recognition Of New Warrants" } } }, "auth_ref": [] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]", "terseLabel": "Insider Trading Arrangements:" } } }, "auth_ref": [ "r297" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]", "terseLabel": "Insider Trading Policies and Procedures:" } } }, "auth_ref": [ "r225", "r303" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]", "terseLabel": "Insider Trading Policies and Procedures Adopted" } } }, "auth_ref": [ "r225", "r303" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]", "terseLabel": "Insider Trading Policies and Procedures Not Adopted" } } }, "auth_ref": [ "r225", "r303" ] }, "ifrs-full_InterestPaidClassifiedAsOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "InterestPaidClassifiedAsOperatingActivities", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest paid", "label": "Interest paid, classified as operating activities" } }, "en": { "role": { "documentation": "The cash outflow for interest paid, classified as operating activities." } } }, "auth_ref": [ "r26" ] }, "ifrs-full_InterestReceivedClassifiedAsOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "InterestReceivedClassifiedAsOperatingActivities", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 30.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Interest received" } }, "en": { "role": { "documentation": "The cash inflow from interest received, classified as operating activities." } } }, "auth_ref": [ "r26" ] }, "ifrs-full_Inventories": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Inventories", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 50.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current inventories", "terseLabel": "Inventories", "totalLabel": "Inventories" } }, "en": { "role": { "documentation": "The amount of current inventories. [Refer: Inventories]" } } }, "auth_ref": [ "r6", "r120", "r167", "r215" ] }, "ifrs-full_InventoryWritedown2011": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "InventoryWritedown2011", "presentation": [ "http://www.evogene.com/role/FinancialInstrumentsNarrativeDetails" ], "lang": { "en-us": { "role": { "positiveTerseLabel": "Inventory impairment", "positiveVerboseLabel": "Inventory impairment", "label": "Inventory write-down", "terseLabel": "Inventory impairment", "verboseLabel": "Inventory impairment" } } }, "auth_ref": [ "r7", "r121", "r189" ] }, "ifrs-full_InvestmentAccountedForUsingEquityMethod": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "InvestmentAccountedForUsingEquityMethod", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Investments accounted for using equity method", "terseLabel": "Investment accounted for using the equity method" } }, "en": { "role": { "documentation": "The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]]" } } }, "auth_ref": [ "r50", "r99", "r149", "r166" ] }, "ifrs-full_InvestmentsInSubsidiaries": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "InvestmentsInSubsidiaries", "crdr": "debit", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Investments in subsidiaries reported in separate financial statements", "terseLabel": "Equity Investment", "verboseLabel": "Investments in subsidiaries" } }, "en": { "role": { "documentation": "The amount of investments in subsidiaries in an entity's separate financial statements. [Refer: Total for all subsidiaries [member]]" } } }, "auth_ref": [ "r11" ] }, "evgn_IssuanceOfOrdinarySharesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "IssuanceOfOrdinarySharesNet", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "documentation": "Represents Issuance of ordinary shares, net.", "label": "Issuance Of Ordinary Shares, Net", "terseLabel": "Issuance of ordinary shares, net of issuance expenses" } } }, "auth_ref": [] }, "evgn_IssuanceOfSubsidiaryOrdinarySharesToCompany": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "IssuanceOfSubsidiaryOrdinarySharesToCompany", "crdr": "debit", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "documentation": "Represent the amount of Issuance of a subsidiary ordinary shares to the company", "label": "Issuance Of Subsidiary Ordinary Shares To Company", "verboseLabel": "Issuance of a subsidiary's ordinary shares to the Company" } } }, "auth_ref": [] }, "evgn_IssuanceOfSubsidiaryPreferredSharesToNonControllingInterests": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "IssuanceOfSubsidiaryPreferredSharesToNonControllingInterests", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "documentation": "Represent the amount of Issuance of a subsidiary preferred shares to non-controlling interests", "label": "Issuance Of Subsidiary Preferred Shares To Non Controlling Interests", "terseLabel": "Shares issuance by a subsidiary to a non-controlling interest", "verboseLabel": "Issuance of a subsidiary's preferred shares to non-controlling interests" } } }, "auth_ref": [] }, "ifrs-full_IssuedCapital": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IssuedCapital", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Issued Capital", "terseLabel": "Ordinary shares of NIS 0.2 par value: Authorized \u2013 30,000,000 ordinary shares; Issued and outstanding \u2013 13,535,843 ordinary shares on June 30, 2026 and 8,718,193 ordinary shares on December 31, 2025" } }, "en": { "role": { "documentation": "The nominal value of capital issued." } } }, "auth_ref": [ "r211", "r217" ] }, "ifrs-full_IssuedCapitalMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IssuedCapitalMember", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Share Capital", "verboseLabel": "Share capital" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing issued capital." } } }, "auth_ref": [ "r162" ] }, "evgn_LavieBioLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "LavieBioLtdMember", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails", "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsNarrativeDetails", "http://www.evogene.com/role/OPERATINGSEGMENTSDetails" ], "lang": { "en-us": { "role": { "documentation": "Lavie Bio Ltd [Member]", "label": "Lavie Bio Ltd [Member]", "verboseLabel": "Lavie Bio Ltd" } } }, "auth_ref": [] }, "ifrs-full_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Liabilities", "totalLabel": "TOTAL LIABILITIES" } }, "en": { "role": { "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r52", "r53", "r54", "r98", "r103", "r150", "r151", "r172" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "LocalPhoneNumber", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "evgn_LongTermDepositsAndOtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "LongTermDepositsAndOtherReceivables", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "documentation": "Represents about long-term deposits and other receivables.", "label": "Long Term Deposits And Other Receivables", "terseLabel": "Long-term deposits and other receivables", "verboseLabel": "Long-term deposits and other receivables" } } }, "auth_ref": [] }, "evgn_LossFromDiscontinuedOperationsNetSharesBasedArrangement": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "LossFromDiscontinuedOperationsNetSharesBasedArrangement", "crdr": "debit", "calculation": { "http://www.evogene.com/role/Share-BasedCompensationScheduleOfCompensationCostOfEquity-basedAwardsDetails": { "parentTag": "ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets", "weight": 1.0, "order": 40.0 } }, "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfCompensationCostOfEquity-basedAwardsDetails" ], "lang": { "en-us": { "role": { "documentation": "Loss from discontinued operations, net related with share based compensation.", "label": "Loss From Discontinued Operations Net Shares Based Arrangement", "verboseLabel": "Loss from discontinued operations, net" } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "MajorCustomersAxis", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesFromMajorCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "auth_ref": [] }, "evgn_MarketingExpensesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "MarketingExpensesReceivable", "crdr": "debit", "presentation": [ "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of grant to be received for marketing expenses.", "label": "Marketing Expenses Receivable", "verboseLabel": "Marketing expenses receivable" } } }, "auth_ref": [] }, "evgn_MaximumGrantsAmountFromSmartMoneyProgram": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "MaximumGrantsAmountFromSmartMoneyProgram", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "The maximum grants amount from Smart money program.", "label": "Maximum Grants Amount From Smart Money Program", "terseLabel": "Maximum grants amount from Smart money program" } } }, "auth_ref": [] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]", "terseLabel": "Measure:" } } }, "auth_ref": [ "r270" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name", "terseLabel": "Name" } } }, "auth_ref": [ "r270" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]", "terseLabel": "MNPI Disclosure Timed for Compensation Value" } } }, "auth_ref": [ "r290" ] }, "evgn_ModificationOfExistingWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ModificationOfExistingWarrants", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/FINANCIALINSTRUMENTSScheduleOfFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "It represents as a modification of existing warrants.", "label": "Modification Of Existing Warrants", "verboseLabel": "Modification of Existing Warrants" } } }, "auth_ref": [] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement [Text Block]", "terseLabel": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r298" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesFromMajorCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]" } } }, "auth_ref": [] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]", "terseLabel": "Named Executive Officers, Footnote" } } }, "auth_ref": [ "r271" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetIncomeLoss", "crdr": "credit", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss)", "terseLabel": "Net Income (Loss)" } } }, "auth_ref": [] }, "evgn_NewOrdinarySharePurchaseWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "NewOrdinarySharePurchaseWarrants", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "The number of new ordinary share purchase warrants.", "label": "New Ordinary Share Purchase Warrants", "terseLabel": "New ordinary share purchase warrants" } } }, "auth_ref": [] }, "evgn_NewWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "NewWarrantsMember", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for new warrants.", "label": "New Warrants [Member]" } } }, "auth_ref": [] }, "evgn_NonCurrentDeferredExpensesRelatedToIssuanceOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "NonCurrentDeferredExpensesRelatedToIssuanceOfWarrants", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 40.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of non current deferred expenses related to issuance of warrants.", "label": "Non Current Deferred Expenses Related To Issuance Of Warrants", "terseLabel": "Deferred expenses related to issuance of warrants" } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]", "terseLabel": "Non-GAAP Measure Description" } } }, "auth_ref": [ "r270" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-NEOs [Member]", "terseLabel": "Non-NEOs" } } }, "auth_ref": [ "r233", "r244", "r254", "r278", "r287" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount", "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r261" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount", "terseLabel": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r260" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO [Member]", "terseLabel": "Non-PEO NEO" } } }, "auth_ref": [ "r278" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r298" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r298" ] }, "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NonadjustingEventsAfterReportingPeriodAxis", "presentation": [ "http://www.evogene.com/role/SUBSEQUENTEVENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Non-adjusting events after reporting period [axis]", "verboseLabel": "Non-adjusting events after reporting period [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r0", "r124" ] }, "ifrs-full_NonadjustingEventsAfterReportingPeriodDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NonadjustingEventsAfterReportingPeriodDomain", "presentation": [ "http://www.evogene.com/role/SUBSEQUENTEVENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Non-adjusting events after reporting period [domain]" } }, "en": { "role": { "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used." } } }, "auth_ref": [ "r0", "r124" ] }, "ifrs-full_NoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncontrollingInterests", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "periodEndLabel": "Balance", "periodStartLabel": "Balance", "label": "Non-controlling interests", "totalLabel": "Total equity attributable to owners of parent" } }, "en": { "role": { "documentation": "The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Total for all subsidiaries [member]]" } } }, "auth_ref": [ "r36", "r38", "r170" ] }, "ifrs-full_NoncontrollingInterestsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncontrollingInterestsMember", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Non-controlling Interests", "verboseLabel": "Non-controlling interests" } }, "en": { "role": { "documentation": "This member stands for equity in a subsidiary not attributable, directly or indirectly, to the parent." } } }, "auth_ref": [ "r162" ] }, "ifrs-full_NoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentAssets", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Total long term assets", "totalLabel": "Total long term assets" } }, "en": { "role": { "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]" } } }, "auth_ref": [ "r42", "r173", "r199" ] }, "ifrs-full_NoncurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentAssetsAbstract", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "LONG-TERM ASSETS:", "verboseLabel": "Non-current assets [abstract]" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentGovernmentGrants": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentGovernmentGrants", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current government grants", "terseLabel": "Liabilities in respect of government grants", "verboseLabel": "Liabilities in respect of government grants" } }, "en": { "role": { "documentation": "The amount of non-current government grants recognised on the statement of financial position as deferred income. [Refer: Government [member]; Government grants]" } } }, "auth_ref": [ "r323" ] }, "ifrs-full_NoncurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 30.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Lease liability", "terseLabel": "Lease liabilities" } }, "en": { "role": { "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r62" ] }, "ifrs-full_NoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentLiabilities", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current liabilities", "totalLabel": "Total long term liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]" } } }, "auth_ref": [ "r44", "r174", "r199" ] }, "ifrs-full_NoncurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentLiabilitiesAbstract", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "LONG-TERM LIABILITIES:" } } }, "auth_ref": [] }, "evgn_NumberAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "NumberAbstract", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfSummarizedNumberOfShareOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Number Abstract" } } }, "auth_ref": [] }, "ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NumberOfInstrumentsOtherEquityInstrumentsGranted", "presentation": [ "http://www.evogene.com/role/SHAREBASEDCOMPENSATIONScheduleOfRestrictedStockUnitsActivityDetails", "http://www.evogene.com/role/Share-BasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Number of other equity instruments granted in share-based payment arrangement", "verboseLabel": "Number of RSUs, Granted" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement." } } }, "auth_ref": [ "r78", "r317" ] }, "evgn_NumberOfOrdinarySharesSold": { "xbrltype": "sharesItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "NumberOfOrdinarySharesSold", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of ordinary shares sold.", "label": "Number Of Ordinary Shares Sold", "verboseLabel": "Number of ordinary shares sold" } } }, "auth_ref": [] }, "ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement", "presentation": [ "http://www.evogene.com/role/SHAREBASEDCOMPENSATIONScheduleOfRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of RSUs, Vested", "positiveLabel": "Number of RSUs, Vested", "label": "Number of other equity instruments exercised or vested in share-based payment arrangement", "terseLabel": "Exercise/vested other equity instrument", "verboseLabel": "Exercise of pre-funded warrants" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement." } } }, "auth_ref": [ "r317" ] }, "ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement", "presentation": [ "http://www.evogene.com/role/SHAREBASEDCOMPENSATIONScheduleOfRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of RSUs, Forfeited", "label": "Number of other equity instruments forfeited in share-based payment arrangement", "verboseLabel": "Number of RSUs, Forfeited" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement." } } }, "auth_ref": [ "r317" ] }, "ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "presentation": [ "http://www.evogene.com/role/SHAREBASEDCOMPENSATIONScheduleOfRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Number of RSUs, Outstanding", "periodStartLabel": "Number of RSUs, Outstanding", "label": "Number of other equity instruments outstanding in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement." } } }, "auth_ref": [ "r317" ] }, "ifrs-full_NumberOfOutstandingShareOptions": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NumberOfOutstandingShareOptions", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfShareOptionsOutstandingDetails", "http://www.evogene.com/role/Share-BasedCompensationScheduleOfSummarizedNumberOfShareOptionsDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Outstanding at end of year", "periodStartLabel": "Outstanding on beginning of year", "label": "Number of options outstanding" } }, "en": { "role": { "documentation": "The number of share options outstanding in a share-based payment arrangement." } } }, "auth_ref": [ "r66", "r70", "r74", "r135", "r139" ] }, "evgn_NumberOfPrefundedWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "NumberOfPrefundedWarrants", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Pre-funded warrants.", "label": "Number Of Prefunded Warrants", "verboseLabel": "Pre-funded warrants" } } }, "auth_ref": [] }, "ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NumberOfShareOptionsExercisableInSharebasedPaymentArrangement", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfSummarizedNumberOfShareOptionsDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Exercisable at end of year", "label": "Number of share options exercisable in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of share options exercisable in a share-based payment arrangement." } } }, "auth_ref": [ "r71", "r140" ] }, "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfSummarizedNumberOfShareOptionsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Exercised", "label": "Number of share options exercised in share-based payment arrangement", "verboseLabel": "Exercise of options and vesting of restricted share units (\u201cRSUs\u201d)" } }, "en": { "role": { "documentation": "The number of share options exercised in a share-based payment arrangement." } } }, "auth_ref": [ "r69", "r138" ] }, "ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfSummarizedNumberOfShareOptionsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Forfeited", "label": "Number of share options forfeited in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of share options forfeited in a share-based payment arrangement." } } }, "auth_ref": [ "r68", "r137" ] }, "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationNarrativeDetails", "http://www.evogene.com/role/Share-BasedCompensationScheduleOfSummarizedNumberOfShareOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Options granted", "verboseLabel": "Granted" } }, "en": { "role": { "documentation": "The number of share options granted in a share-based payment arrangement." } } }, "auth_ref": [ "r67", "r136" ] }, "ifrs-full_NumberOfSharesAuthorised": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NumberOfSharesAuthorised", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPositionParenthetical" ], "lang": { "en-us": { "role": { "label": "Ordinary shares, Authorized", "terseLabel": "Ordinary shares, authorized", "verboseLabel": "Ordinary shares of NIS 0.02 par value, Authorized" } }, "en": { "role": { "documentation": "The number of shares authorised." } } }, "auth_ref": [ "r116", "r152", "r177" ] }, "ifrs-full_NumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NumberOfSharesIssued", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPositionParenthetical", "http://www.evogene.com/role/GeneralNarrativeDetails", "http://www.evogene.com/role/SUBSEQUENTEVENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Number of shares issued", "terseLabel": "Number of shares purchased", "verboseLabel": "Ordinary shares issued" } }, "en": { "role": { "documentation": "The number of shares issued by the entity." } } }, "auth_ref": [ "r321" ] }, "ifrs-full_NumberOfSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NumberOfSharesOutstanding", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPositionParenthetical" ], "lang": { "en-us": { "role": { "label": "Ordinary shares, Outstanding", "terseLabel": "Ordinary shares, outstanding" } }, "en": { "role": { "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]" } } }, "auth_ref": [ "r118", "r154", "r179" ] }, "evgn_NumberOfUnderlyingOrdinarySharesPurchased": { "xbrltype": "sharesItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "NumberOfUnderlyingOrdinarySharesPurchased", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents number of underlying ordinary shares purchased.", "label": "Number Of Underlying Ordinary Shares Purchased", "terseLabel": "Number of underlying ordinary shares purchased" } } }, "auth_ref": [] }, "evgn_OfficeOfChiefScientistMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "OfficeOfChiefScientistMember", "presentation": [ "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "OCS [Member]", "label": "Office Of Chief Scientist Member", "verboseLabel": "IIA [Member]" } } }, "auth_ref": [] }, "ifrs-full_OperatingExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OperatingExpense", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss" ], "lang": { "en-us": { "role": { "label": "Total operating expenses", "totalLabel": "Total operating expenses, net" } } }, "auth_ref": [ "r325" ] }, "evgn_OperatingExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "OperatingExpenseAbstract", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss" ], "lang": { "en-us": { "role": { "label": "Operating Expense Abstract", "terseLabel": "Operating expenses (income):" } } }, "auth_ref": [] }, "evgn_OperatingSegmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "OperatingSegmentsAbstract", "lang": { "en-us": { "role": { "label": "Operating Segments Abstract" } } }, "auth_ref": [] }, "ifrs-full_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OperatingSegmentsMember", "presentation": [ "http://www.evogene.com/role/OPERATINGSEGMENTSDetails" ], "lang": { "en-us": { "role": { "label": "Operating segments [member]" } } }, "auth_ref": [ "r105" ] }, "ifrs-full_OtherCurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherCurrentPayables", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Other payables" } }, "en": { "role": { "documentation": "The amount of current payables that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r323" ] }, "ifrs-full_OtherCurrentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherCurrentReceivables", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 40.0 }, "http://www.evogene.com/role/OtherReceivablesAndPrepaidExpensesScheduleOfOtherReceivablesAndPrepaidExpensesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.evogene.com/role/OtherReceivablesAndPrepaidExpensesScheduleOfOtherReceivablesAndPrepaidExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Other receivables and prepaid expenses", "totalLabel": "Other receivables", "verboseLabel": "Other receivables and prepaid expenses" } }, "en": { "role": { "documentation": "The amount of current other receivables. [Refer: Other receivables]" } } }, "auth_ref": [ "r210", "r216" ] }, "ifrs-full_OtherOperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherOperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss": { "parentTag": "ifrs-full_OperatingExpense", "weight": -1.0, "order": 30.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Other expenses (income)", "label": "Other operating income (expense)", "terseLabel": "Other income" } } }, "auth_ref": [ "r325" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount", "terseLabel": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r270" ] }, "ifrs-full_OtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherReceivables", "crdr": "debit", "calculation": { "http://www.evogene.com/role/OtherReceivablesAndPrepaidExpensesScheduleOfOtherReceivablesAndPrepaidExpensesDetails": { "parentTag": "ifrs-full_OtherCurrentReceivables", "weight": 1.0, "order": 70.0 } }, "presentation": [ "http://www.evogene.com/role/OtherReceivablesAndPrepaidExpensesScheduleOfOtherReceivablesAndPrepaidExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Other" } }, "en": { "role": { "documentation": "The amount receivable by the entity that it does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r210", "r216" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount", "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r231", "r242", "r252", "r285" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount", "terseLabel": "Compensation Amount" } } }, "auth_ref": [ "r234", "r245", "r255", "r288" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r234", "r245", "r255", "r288" ] }, "evgn_OwnershipPercentageHeldByOtherEntityInSubsidiary": { "xbrltype": "percentItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "OwnershipPercentageHeldByOtherEntityInSubsidiary", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails", "http://www.evogene.com/role/OPERATINGSEGMENTSDetails" ], "lang": { "en-us": { "role": { "documentation": "Ownership percentage held by other entity in subsidiary.", "label": "Ownership Percentage Held By Other Entity In Subsidiary", "verboseLabel": "Ownership percentage held by other entity in subsidiary" } } }, "auth_ref": [] }, "ifrs-full_ParValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ParValuePerShare", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPositionParenthetical", "http://www.evogene.com/role/GeneralNarrativeDetails", "http://www.evogene.com/role/SUBSEQUENTEVENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Par value per share", "terseLabel": "Ordinary shares par value", "verboseLabel": "Ordinary shares per share" } }, "en": { "role": { "documentation": "The nominal value per share." } } }, "auth_ref": [ "r117", "r153", "r178" ] }, "evgn_PatentCostReimbursementCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "PatentCostReimbursementCurrent", "crdr": "debit", "calculation": { "http://www.evogene.com/role/OtherReceivablesAndPrepaidExpensesScheduleOfOtherReceivablesAndPrepaidExpensesDetails": { "parentTag": "ifrs-full_OtherCurrentReceivables", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://www.evogene.com/role/OtherReceivablesAndPrepaidExpensesScheduleOfOtherReceivablesAndPrepaidExpensesDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of patent cost reimbursement.", "label": "Patent Cost Reimbursement Current", "verboseLabel": "Patent cost reimbursement" } } }, "auth_ref": [] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r259" ] }, "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "weight": -1.0, "order": 50.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment of lease liability", "label": "Payments of lease liabilities, classified as financing activities" } }, "en": { "role": { "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r198" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]", "terseLabel": "Peer Group Issuers, Footnote" } } }, "auth_ref": [ "r269" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount", "terseLabel": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r269" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount", "terseLabel": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r261" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO [Member]", "terseLabel": "PEO" } } }, "auth_ref": [ "r278" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name", "terseLabel": "PEO Name" } } }, "auth_ref": [ "r271" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount", "terseLabel": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r260" ] }, "evgn_PercentageOfEntityAccordingToLocation": { "xbrltype": "percentItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "PercentageOfEntityAccordingToLocation", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsScheduleOfPercentageOfNon-currentAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of entity according to location.", "label": "Percentage Of Entity According To Location", "terseLabel": "Percentage of entity according to location" } } }, "auth_ref": [] }, "ifrs-full_PercentageOfEntitysRevenue": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PercentageOfEntitysRevenue", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesBasedOnCustomersDetails", "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesFromMajorCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Additional information about revenues", "terseLabel": "Percentage of entity revenues from major customers", "verboseLabel": "Percentage of entity revenues from locations" } } }, "auth_ref": [ "r319" ] }, "evgn_PercentageOfGrantReceived": { "xbrltype": "percentItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "PercentageOfGrantReceived", "presentation": [ "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of grant received.", "label": "Percentage Of Grant Received", "verboseLabel": "Percentage of grant received" } } }, "auth_ref": [] }, "evgn_PercentageOfRoyaltiesCompanyUndertookToPayDescription": { "xbrltype": "stringItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "PercentageOfRoyaltiesCompanyUndertookToPayDescription", "presentation": [ "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of royalties the company undertook to pay description.", "label": "Percentage Of Royalties Company Undertook To Pay Description", "verboseLabel": "Percentage of royalties the company undertook to pay" } } }, "auth_ref": [] }, "ecd_PnsnAdjsPrrSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PnsnAdjsPrrSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Adjustments Prior Service Cost [Member]", "terseLabel": "Pension Adjustments Prior Service Cost" } } }, "auth_ref": [ "r262" ] }, "ecd_PnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Adjustments Service Cost [Member]", "terseLabel": "Pension Adjustments Service Cost" } } }, "auth_ref": [ "r307" ] }, "ecd_PnsnBnftsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PnsnBnftsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Benefits Adjustments, Footnote [Text Block]", "terseLabel": "Pension Benefits Adjustments, Footnote" } } }, "auth_ref": [ "r261" ] }, "ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/ASSETSHELDFORSALEANDDISCONTINUEDOPERATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Portion of consideration paid (received) consisting of cash and cash equivalents", "verboseLabel": "Total cash consideration to be received in respect of Asset Purchase agreement" } }, "en": { "role": { "documentation": "The portion of consideration paid or received, consisting of cash and cash equivalents, in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Total for all subsidiaries [member]; Cash and cash equivalents; Consideration paid (received)]" } } }, "auth_ref": [ "r28" ] }, "evgn_PostvestingForfeitureRate": { "xbrltype": "percentItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "PostvestingForfeitureRate", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfAssumptionsUsedToValueOptionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The percentage of an expected forfeiture rate used to calculate the fair value of share options granted.", "label": "Postvesting Forfeiture Rate", "verboseLabel": "Post-vesting forfeiture rate (%)" } } }, "auth_ref": [] }, "evgn_PrefundedWarrantPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "PrefundedWarrantPerShare", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Pre-funded warrant per share.", "label": "Prefunded Warrant Per Share", "verboseLabel": "Pre-funded warrant per share" } } }, "auth_ref": [] }, "evgn_PresidentAndChiefExecutiveOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "PresidentAndChiefExecutiveOfficerMember", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "President and Chief Executive Officer [Member]", "label": "President And Chief Executive Officer [Member]", "terseLabel": "President and Chief Executive Officer [Member]" } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromExerciseOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProceedsFromExerciseOfWarrants", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows", "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from exercise of warrants", "terseLabel": "Proceeds from issuance of ordinary shares in warrant inducement transaction, net of issuance expenses" } }, "en": { "role": { "documentation": "The cash inflow from the exercise of share purchase warrants." } } }, "auth_ref": [ "r312" ] }, "evgn_ProceedsFromFinanceSubLeaseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ProceedsFromFinanceSubLeaseAsset", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "weight": 1.0, "order": 30.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of proceeds from finance sub lease asset.", "label": "Proceeds From Finance Sub Lease Asset", "verboseLabel": "Proceeds from finance sub-lease asset" } } }, "auth_ref": [] }, "evgn_ProceedsFromGovernmentGrants": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ProceedsFromGovernmentGrants", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "weight": 1.0, "order": 40.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Represent the amount of Proceeds from government grants", "label": "Proceeds From Government Grants" } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromIssueOfOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProceedsFromIssueOfOrdinaryShares", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows", "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from issue of ordinary shares", "terseLabel": "Proceeds from issuance of ordinary shares, net of issuance expenses", "verboseLabel": "Gross proceeds from ordinary shares" } }, "en": { "role": { "documentation": "The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]" } } }, "auth_ref": [ "r312" ] }, "evgn_ProceedsFromIssueOfOrdinarySharesAndPreFundedWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ProceedsFromIssueOfOrdinarySharesAndPreFundedWarrants", "crdr": "debit", "presentation": [ "http://www.evogene.com/role/SUBSEQUENTEVENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuing of ordinary shares and pre-funded warrants.", "label": "Proceeds From Issue Of Ordinary Shares And Pre Funded Warrants", "verboseLabel": "Gross proceeds from ordinary shares and pre-funded warrants" } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from sales of property, plant and equipment, classified as investing activities", "verboseLabel": "Proceeds from sale of property, plant and equipment" } }, "en": { "role": { "documentation": "The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r197" ] }, "ifrs-full_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss__1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.evogene.com/role/ASSETSHELDFORSALEANDDISCONTINUEDOPERATIONSDetails1", "http://www.evogene.com/role/ConsolidatedStatementsOfChangesInEquity", "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Loss", "positiveLabel": "Loss", "label": "Profit (loss)", "terseLabel": "Loss", "totalLabel": "Loss", "verboseLabel": "Loss after taxes on income" } }, "en": { "role": { "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r33", "r35", "r98", "r101", "r131", "r134", "r160", "r181", "r199", "r203" ] }, "ifrs-full_ProfitLossAttributableToAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossAttributableToAbstract", "presentation": [ "http://www.evogene.com/role/ASSETSHELDFORSALEANDDISCONTINUEDOPERATIONSDetails1", "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss" ], "lang": { "en-us": { "role": { "label": "Profit (loss), attributable to [abstract]", "terseLabel": "Attributable to:" } } }, "auth_ref": [] }, "ifrs-full_ProfitLossAttributableToNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossAttributableToNoncontrollingInterests", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss__1": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/ASSETSHELDFORSALEANDDISCONTINUEDOPERATIONSDetails1", "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss" ], "lang": { "en-us": { "role": { "positiveLabel": "Non-controlling interests", "label": "Profit (loss), attributable to non-controlling interests", "terseLabel": "Loss attributed to non-controlling interests", "verboseLabel": "Non-controlling interests" } }, "en": { "role": { "documentation": "The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]" } } }, "auth_ref": [ "r37", "r182" ] }, "ifrs-full_ProfitLossAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss__1": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.evogene.com/role/ASSETSHELDFORSALEANDDISCONTINUEDOPERATIONSDetails1", "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss" ], "lang": { "en-us": { "role": { "label": "Profit (loss), attributable to owners of parent", "terseLabel": "Equity holders of the Company" } }, "en": { "role": { "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r183" ] }, "ifrs-full_ProfitLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossBeforeTax", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss": { "parentTag": "ifrs-full_ProfitLossFromContinuingOperations", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/ASSETSHELDFORSALEANDDISCONTINUEDOPERATIONSDetails1", "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss", "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesAndOperatingLossBySegmentsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Loss before taxes on income", "label": "Profit (loss) before tax", "totalLabel": "Loss before taxes on income", "verboseLabel": "Loss before taxes on income" } } }, "auth_ref": [ "r84", "r206", "r207", "r212", "r213" ] }, "ifrs-full_ProfitLossFromContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossFromContinuingOperations", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 0.0 }, "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows", "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Loss", "label": "Profit (loss) from continuing operations", "terseLabel": "Loss from continuing operations", "totalLabel": "Loss from continuing operations", "verboseLabel": "Loss from continuing operations" } }, "en": { "role": { "documentation": "The profit (loss) from continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Profit (loss)]" } } }, "auth_ref": [ "r46", "r98", "r101", "r181" ] }, "ifrs-full_ProfitLossFromDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossFromDiscontinuedOperations", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/ASSETSHELDFORSALEANDDISCONTINUEDOPERATIONSDetails1", "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss", "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "positiveLabel": "Loss from discontinued operations, net", "label": "Profit (loss) from discontinued operations", "terseLabel": "Loss from discontinued operations", "totalLabel": "Loss from discontinued operations, net", "verboseLabel": "Loss after taxes on income" } } }, "auth_ref": [ "r47", "r83", "r188", "r190" ] }, "ifrs-full_ProfitLossFromOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossFromOperatingActivities", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.evogene.com/role/ASSETSHELDFORSALEANDDISCONTINUEDOPERATIONSDetails1", "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss", "http://www.evogene.com/role/GeneralNarrativeDetails", "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesAndOperatingLossBySegmentsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Operating loss", "label": "Profit (loss) from operating activities", "totalLabel": "Operating loss" } } }, "auth_ref": [ "r195", "r325" ] }, "ifrs-full_PropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "periodEndLabel": "Balance on end of year", "periodStartLabel": "Balance on beginning year", "label": "Property, plant and equipment", "terseLabel": "Property, plant and equipment, net", "verboseLabel": "Property, plant and equipment, net" } }, "en": { "role": { "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]" } } }, "auth_ref": [ "r5", "r128", "r165" ] }, "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProportionOfOwnershipInterestInSubsidiary", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Proportion of ownership interest in subsidiary", "terseLabel": "Proportion of ownership interest in subsidiary", "verboseLabel": "Proportion of ownership interest in equity accounted investment" } }, "en": { "role": { "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Total for all subsidiaries [member]]" } } }, "auth_ref": [ "r12", "r14", "r39" ] }, "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of property, plant and equipment", "label": "Purchase of property, plant and equipment, classified as investing activities" } }, "en": { "role": { "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r196" ] }, "evgn_PurchasePricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "PurchasePricePerShare", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the purchase price per share.", "label": "Purchase Price Per Share", "verboseLabel": "Purchase price per share" } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r259" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]", "terseLabel": "Pay vs Performance Disclosure, Table" } } }, "auth_ref": [ "r259" ] }, "ifrs-full_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RangeAxis", "presentation": [ "http://www.evogene.com/role/FinancialInstrumentsNarrativeDetails", "http://www.evogene.com/role/Share-BasedCompensationScheduleOfAssumptionsUsedToValueOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Range [axis]", "verboseLabel": "Range [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r29", "r55", "r64", "r74", "r122", "r200", "r201", "r318" ] }, "ifrs-full_RangeDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RangeDomain", "presentation": [ "http://www.evogene.com/role/FinancialInstrumentsNarrativeDetails", "http://www.evogene.com/role/Share-BasedCompensationScheduleOfAssumptionsUsedToValueOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Range [domain]" } }, "en": { "role": { "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used." } } }, "auth_ref": [ "r29", "r55", "r64", "r74", "r122", "r200", "r201", "r318" ] }, "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RangesOfExercisePricesForOutstandingShareOptionsAxis", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfShareOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Ranges of exercise prices for outstanding share options [Axis]", "verboseLabel": "Ranges of exercise prices for outstanding share options [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r74" ] }, "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RangesOfExercisePricesForOutstandingShareOptionsDomain", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfShareOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Ranges of exercise prices for outstanding share options [domain]" } }, "en": { "role": { "documentation": "This member stands for aggregated ranges of exercise prices for outstanding share options that are meaningful for assessing the number and timing of additional shares that may be issued and the cash that may be received upon exercise of those options. It also represents the standard value for the 'Ranges of exercise prices for outstanding share options' axis if no other member is used. [Refer: Range [domain]]" } } }, "auth_ref": [ "r74" ] }, "evgn_ReceivedResearchAndDevelopmentGrantsOfBirdAmounting": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ReceivedResearchAndDevelopmentGrantsOfBirdAmounting", "crdr": "debit", "presentation": [ "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Received research and development grants of BIRD amounting.", "label": "Received Research And Development Grants Of Bird Amounting", "verboseLabel": "Research and development grants" } } }, "auth_ref": [] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]", "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure" } } }, "auth_ref": [ "r226", "r237", "r247", "r280" ] }, "evgn_RedeemSimpleAgreementForFutureEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "RedeemSimpleAgreementForFutureEquity", "crdr": "debit", "presentation": [ "http://www.evogene.com/role/ASSETSHELDFORSALEANDDISCONTINUEDOPERATIONSNarrativeDetails", "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of redeemable Simple Agreement for Future Equity (SAFE)", "label": "Redeem Simple Agreement For Future Equity", "terseLabel": "Amount from redeem SAFE" } } }, "auth_ref": [] }, "evgn_ReducedExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ReducedExercisePrice", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents reduced exercise price.", "label": "Reduced Exercise Price", "terseLabel": "Reduced exercise price" } } }, "auth_ref": [] }, "ifrs-full_RentDeferredIncomeClassifiedAsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RentDeferredIncomeClassifiedAsCurrent", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 30.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Deferred revenues and other advances" } }, "en": { "role": { "documentation": "The amount of rent deferred income classified as current. [Refer: Rent deferred income]" } } }, "auth_ref": [ "r324" ] }, "evgn_RepaymentOfGovernmentGrantsClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "RepaymentOfGovernmentGrantsClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "weight": -1.0, "order": 30.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "THe cash outflow of repayment of government grants.", "negatedLabel": "Repayment of government grants", "label": "Repayment Of Government Grants Classified As Financing Activities" } } }, "auth_ref": [] }, "ifrs-full_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss": { "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss" ], "lang": { "en-us": { "role": { "label": "Research and development, net", "totalLabel": "Research and development expenses" } } }, "auth_ref": [ "r21", "r132" ] }, "evgn_ResearchAndDevelopmentExpenseSharesBasedArrangement": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ResearchAndDevelopmentExpenseSharesBasedArrangement", "crdr": "debit", "calculation": { "http://www.evogene.com/role/Share-BasedCompensationScheduleOfCompensationCostOfEquity-basedAwardsDetails": { "parentTag": "ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfCompensationCostOfEquity-basedAwardsDetails" ], "lang": { "en-us": { "role": { "documentation": "Research and development expenses related with share based compensation.", "label": "Research And Development Expense Shares Based Arrangement", "verboseLabel": "Research and development, net" } } }, "auth_ref": [] }, "evgn_ResearchAndDevelopmentSellingGeneralAndAdministrativeExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ResearchAndDevelopmentSellingGeneralAndAdministrativeExpenses", "crdr": "debit", "presentation": [ "http://www.evogene.com/role/ASSETSHELDFORSALEANDDISCONTINUEDOPERATIONSDetails1" ], "lang": { "en-us": { "role": { "documentation": "Research and development, Selling, general and administrative expenses.", "label": "Research And Development, Selling, General And Administrative Expenses", "terseLabel": "Research and development, Selling, general and administrative expenses" } } }, "auth_ref": [] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]", "terseLabel": "Restatement Determination Date:" } } }, "auth_ref": [ "r227", "r238", "r248", "r281" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date", "terseLabel": "Restatement Determination Date" } } }, "auth_ref": [ "r228", "r239", "r249", "r282" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]", "terseLabel": "Restatement does not require Recovery" } } }, "auth_ref": [ "r235", "r246", "r256", "r289" ] }, "ifrs-full_RestrictedCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RestrictedCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://www.evogene.com/role/OtherReceivablesAndPrepaidExpensesScheduleOfOtherReceivablesAndPrepaidExpensesDetails": { "parentTag": "ifrs-full_OtherCurrentReceivables", "weight": 1.0, "order": 50.0 } }, "presentation": [ "http://www.evogene.com/role/OtherReceivablesAndPrepaidExpensesScheduleOfOtherReceivablesAndPrepaidExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Restricted cash" } }, "en": { "role": { "documentation": "The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r323" ] }, "evgn_RestrictedCashs": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "RestrictedCashs", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "documentation": "Represent the amount of the Restricted Cash", "label": "Restricted Cashs", "terseLabel": "Restricted cash" } } }, "auth_ref": [] }, "evgn_RestrictedStockUnitVested": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "RestrictedStockUnitVested", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "documentation": "Represents restricted stock unit vested.", "label": "Restricted Stock Unit Vested", "terseLabel": "RSUs vested" } } }, "auth_ref": [] }, "evgn_RestrictedStockUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "RestrictedStockUnitsMember", "presentation": [ "http://www.evogene.com/role/SHAREBASEDCOMPENSATIONScheduleOfRestrictedStockUnitsActivityDetails", "http://www.evogene.com/role/SUBSEQUENTEVENTSNarrativeDetails", "http://www.evogene.com/role/Share-BasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for restricted stock units.", "label": "Restricted Stock Units [Member]", "verboseLabel": "Restricted Share Units (RSUs) [Member]" } } }, "auth_ref": [] }, "ifrs-full_RetainedEarnings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RetainedEarnings", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition", "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Retained earnings", "verboseLabel": "Accumulated deficit" } }, "en": { "role": { "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r211", "r217", "r218" ] }, "ifrs-full_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RetainedEarningsMember", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "terseLabel": "Accumulated deficit" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r162", "r214" ] }, "evgn_RevaluationOfGovernmentGrants": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "RevaluationOfGovernmentGrants", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": -1.0, "order": 80.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Represent the amount of Revaluation of government grants", "negatedLabel": "Revaluation of government grants", "label": "Revaluation Of Government Grants" } } }, "auth_ref": [] }, "ifrs-full_Revenue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Revenue", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss": { "parentTag": "ifrs-full_GrossProfit", "weight": 1.0, "order": 0.0 }, "http://www.evogene.com/role/REVENUEFROMCONTRACTSWITHCUSTOMERSScheduleOfRevenuesByTimingOfRevenueRecognitionDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.evogene.com/role/ASSETSHELDFORSALEANDDISCONTINUEDOPERATIONSDetails1", "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss", "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesAndOperatingLossBySegmentsDetails", "http://www.evogene.com/role/REVENUEFROMCONTRACTSWITHCUSTOMERSScheduleOfRevenuesByTimingOfRevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "label": "Revenue", "terseLabel": "Revenues", "totalLabel": "Revenue", "verboseLabel": "Order amount" } } }, "auth_ref": [ "r45", "r84", "r95", "r100", "r106", "r107", "r109", "r184", "r199", "r212", "r213" ] }, "ifrs-full_RevenueFromContractsWithCustomers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RevenueFromContractsWithCustomers", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/OPERATINGSEGMENTSDetails" ], "lang": { "en-us": { "role": { "label": "Revenue from contracts with customers" } } }, "auth_ref": [ "r56", "r57", "r111" ] }, "ifrs-full_RevenueFromRenderingOfServicesRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RevenueFromRenderingOfServicesRelatedPartyTransactions", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/OPERATINGSEGMENTSDetails" ], "lang": { "en-us": { "role": { "label": "Revenue from rendering of services, related party transactions", "verboseLabel": "Recognition of revenue of related party" } } }, "auth_ref": [ "r194", "r209" ] }, "evgn_RevenueRecognizedAtPointInTime": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "RevenueRecognizedAtPointInTime", "crdr": "credit", "calculation": { "http://www.evogene.com/role/REVENUEFROMCONTRACTSWITHCUSTOMERSScheduleOfRevenuesByTimingOfRevenueRecognitionDetails": { "parentTag": "ifrs-full_Revenue", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/REVENUEFROMCONTRACTSWITHCUSTOMERSScheduleOfRevenuesByTimingOfRevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "documentation": "Represent the amount of revenue recognized at a point in time.", "label": "Revenue Recognized At Point In Time", "terseLabel": "Revenue recognized at a point in time, attributable to industrial segment" } } }, "auth_ref": [] }, "evgn_RevenueRecognizedOverTime": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "RevenueRecognizedOverTime", "crdr": "credit", "calculation": { "http://www.evogene.com/role/REVENUEFROMCONTRACTSWITHCUSTOMERSScheduleOfRevenuesByTimingOfRevenueRecognitionDetails": { "parentTag": "ifrs-full_Revenue", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.evogene.com/role/REVENUEFROMCONTRACTSWITHCUSTOMERSScheduleOfRevenuesByTimingOfRevenueRecognitionDetails" ], "lang": { "en-us": { "role": { "documentation": "Represent the amount of revenue recognized over time.", "label": "Revenue Recognized Over Time", "terseLabel": "Revenue recognized over time, attributable to agriculture and unallocated segment" } } }, "auth_ref": [] }, "ifrs-full_RightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RightofuseAssets", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 30.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "periodEndLabel": "Balance at end of year", "periodStartLabel": "Balance at beginning year", "label": "Right-of-use-assets", "verboseLabel": "Right-of-use-assets" } }, "en": { "role": { "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee." } } }, "auth_ref": [ "r61", "r63", "r113" ] }, "evgn_RoyaltiesPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "RoyaltiesPaid", "crdr": "debit", "presentation": [ "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsScheduleOfLiabilitiesInRespectOfGovernmentGrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of royalty paid.", "label": "Royalties Paid", "verboseLabel": "Royalties paid" } } }, "auth_ref": [] }, "ifrs-full_RoyaltyExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RoyaltyExpense", "crdr": "debit", "presentation": [ "http://www.evogene.com/role/LiabilitiesInRespectOfGovernmentGrantsNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Royalty expense", "verboseLabel": "Payment for pay royalties" } } }, "auth_ref": [ "r325" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r298" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r298" ] }, "ifrs-full_SalesAndMarketingExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SalesAndMarketingExpense", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss": { "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss" ], "lang": { "en-us": { "role": { "label": "Sales and marketing expense", "terseLabel": "Sales and marketing", "totalLabel": "Total sales and marketing" } } }, "auth_ref": [ "r325" ] }, "evgn_SalesAndMarketingExpenseSharesBasedArrangement": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "SalesAndMarketingExpenseSharesBasedArrangement", "crdr": "debit", "calculation": { "http://www.evogene.com/role/Share-BasedCompensationScheduleOfCompensationCostOfEquity-basedAwardsDetails": { "parentTag": "ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets", "weight": 1.0, "order": 30.0 } }, "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfCompensationCostOfEquity-basedAwardsDetails" ], "lang": { "en-us": { "role": { "documentation": "Sales and marketing expense related with share based compensation.", "label": "Sales And Marketing Expense Shares Based Arrangement", "terseLabel": "Sales and marketing" } } }, "auth_ref": [] }, "evgn_SecuritiesPurchaseAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "SecuritiesPurchaseAgreementsMember", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for securities purchase agreements.", "label": "Securities Purchase Agreements [Member]", "verboseLabel": "Securities purchase agreements [Member]" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "Security12bTitle", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r220" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SecurityExchangeName", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r222" ] }, "ifrs-full_SegmentConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SegmentConsolidationItemsAxis", "presentation": [ "http://www.evogene.com/role/OPERATINGSEGMENTSDetails" ], "lang": { "en-us": { "role": { "label": "Segment consolidation items [axis]", "verboseLabel": "Segments [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r98" ] }, "ifrs-full_SegmentConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SegmentConsolidationItemsDomain", "presentation": [ "http://www.evogene.com/role/OPERATINGSEGMENTSDetails" ], "lang": { "en-us": { "role": { "label": "Segment consolidation items [domain]" } }, "en": { "role": { "documentation": "This member stands for the standard value for the 'Segment consolidation items' axis if no other member is used." } } }, "auth_ref": [ "r105" ] }, "ifrs-full_SegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SegmentsAxis", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesAndOperatingLossBySegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Segments [axis]", "verboseLabel": "Segments [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r20", "r58", "r98", "r112", "r193", "r205" ] }, "ifrs-full_SegmentsDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SegmentsDomain", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesAndOperatingLossBySegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Segments [domain]" } }, "en": { "role": { "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used." } } }, "auth_ref": [ "r20", "r58", "r105", "r112", "r193", "r205" ] }, "evgn_SellPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "SellPricePerShare", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents about sell price per share.", "label": "Sell Price Per Share", "terseLabel": "Sell price per share" } } }, "auth_ref": [] }, "ifrs-full_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss": { "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss" ], "lang": { "en-us": { "role": { "label": "General and administrative", "totalLabel": "General and administrative expenses" } } }, "auth_ref": [ "r325" ] }, "evgn_SeriesAAndBOrdinaryWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "SeriesAAndBOrdinaryWarrantMember", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Series A and B ordinary warrant [Member].", "label": "Series A And B Ordinary Warrant [Member]" } } }, "auth_ref": [] }, "evgn_SeriesAOrdinaryWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "SeriesAOrdinaryWarrantMember", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Series A Ordinary Warrant [Member].", "label": "Series A Ordinary Warrant [Member]" } } }, "auth_ref": [] }, "evgn_SeriesBOrdinaryWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "SeriesBOrdinaryWarrantMember", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Series B Ordinary Warrant [Member].", "label": "Series B Ordinary Warrant [Member]" } } }, "auth_ref": [] }, "evgn_ShanghaiHealthcareCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ShanghaiHealthcareCapitalMember", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stand for Shanghai Healthcare Capital [Member].", "label": "Shanghai Healthcare Capital [Member]", "verboseLabel": "Shanghai Healthcare Capital [Member]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "All Award Types", "terseLabel": "All Award Types" } } }, "auth_ref": [] }, "evgn_ShareBasedCompensationExpensesRelatedToDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ShareBasedCompensationExpensesRelatedToDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount represents share based compensation xpenses related to discontinued operations.", "label": "Share Based Compensation Expenses Related To Discontinued Operations", "terseLabel": "Share-based compensation expenses related to discontinued operations" } } }, "auth_ref": [] }, "evgn_ShareOfLossFromEquityAccountedInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ShareOfLossFromEquityAccountedInvestment", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of share of loss from equity accounted investment.", "negatedLabel": "Share of loss from equity accounted investment", "negatedTerseLabel": "Share of loss from equity accounted investment", "label": "Share Of Loss From Equity Accounted Investment", "terseLabel": "Share of loss from equity accounted investment", "verboseLabel": "Share of loss from equity accounted investment" } } }, "auth_ref": [] }, "evgn_ShareOfLossOfAnAssociate": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ShareOfLossOfAnAssociate", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss", "weight": -1.0, "order": 120.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of associated Company loss share.", "negatedLabel": "Share of loss of an associate", "negatedTerseLabel": "Share of loss of an associate", "label": "Share Of Loss Of An Associate", "terseLabel": "Associated Company loss share", "verboseLabel": "Share of loss of an associate" } } }, "auth_ref": [] }, "ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesAndOperatingLossBySegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Share of profit (loss) of associates and joint ventures accounted for using equity method", "verboseLabel": "Share of loss from equity accounted investment" } } }, "auth_ref": [ "r96", "r104", "r186" ] }, "evgn_ShareOptionAndIncentivePlansDescription": { "xbrltype": "stringItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "ShareOptionAndIncentivePlansDescription", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "The description of the share option and incentive plans the entity maintains.", "label": "Share Option And Incentive Plans Description", "verboseLabel": "Share option and incentive plans description" } } }, "auth_ref": [] }, "ifrs-full_SharePremiumMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SharePremiumMember", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Share premium and other capital reserve", "verboseLabel": "Share premium and other capital reserves" } }, "en": { "role": { "documentation": "This member stands for the amount received or receivable from issuance of the entity's shares in excess of nominal value." } } }, "auth_ref": [ "r162" ] }, "ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Number of shares reserved for issue under options and contracts for sale of shares", "verboseLabel": "Number of options approved to grant" } }, "en": { "role": { "documentation": "The number of shares reserved for issue under options and contracts for the sale of shares." } } }, "auth_ref": [ "r119", "r155", "r180" ] }, "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SignificantInvestmentsInSubsidiariesAxis", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Subsidiaries [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r13", "r15", "r51", "r148" ] }, "ifrs-full_SignificantInvestmentsInSubsidiariesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SignificantInvestmentsInSubsidiariesDomain", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Subsidiaries [domain]" } }, "en": { "role": { "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used." } } }, "auth_ref": [ "r13", "r15", "r51", "r148" ] }, "evgn_SignificantNoncashInvestingTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "SignificantNoncashInvestingTransactionsAbstract", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Significant Noncash Investing Transactions Abstract", "verboseLabel": "Significant non-cash activities:" } } }, "auth_ref": [] }, "ifrs-full_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of cash flows [abstract]" } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "StatementOfChangesInEquityAbstract", "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "StatementOfChangesInEquityLineItems", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Statement of changes in equity [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "StatementOfChangesInEquityTable", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Statement of changes in equity [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to changes in equity." } } }, "auth_ref": [ "r162" ] }, "ifrs-full_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of financial position [abstract]" } } }, "auth_ref": [] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]", "terseLabel": "Stock Price or TSR Estimation Method" } } }, "auth_ref": [ "r230", "r241", "r251", "r284" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Appreciation Rights (SARs) [Member]", "terseLabel": "Stock Appreciation Rights (SARs)" } } }, "auth_ref": [] }, "evgn_StockholdersEquityReverseShareSplit": { "xbrltype": "stringItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "StockholdersEquityReverseShareSplit", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.", "label": "Stockholders Equity, Reverse Share Split", "verboseLabel": "Reverse share split ratio" } } }, "auth_ref": [] }, "evgn_SuboptimalFactor": { "xbrltype": "decimalItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "SuboptimalFactor", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfAssumptionsUsedToValueOptionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Suboptimal factor", "label": "Suboptimal Factor", "verboseLabel": "Suboptimal factor" } } }, "auth_ref": [] }, "evgn_SubsequentEventsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "SubsequentEventsMember", "presentation": [ "http://www.evogene.com/role/SUBSEQUENTEVENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Subsequent Events [Member].", "label": "Subsequent Events [Member]", "verboseLabel": "Subsequent Events [Member]" } } }, "auth_ref": [] }, "evgn_SubsidiariesEmployeesConsultantsDirectorsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "SubsidiariesEmployeesConsultantsDirectorsMember", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfAssumptionsUsedToValueOptionsDetails", "http://www.evogene.com/role/Share-BasedCompensationScheduleOfSummarizedNumberOfShareOptionsDetails", "http://www.evogene.com/role/Share-BasedCompensationTables" ], "lang": { "en-us": { "role": { "documentation": "Subsidiaries Employees Consultants and Directors [Member]", "label": "Subsidiaries Employees Consultants Directors Member", "verboseLabel": "Subsidiaries\u2019 options granted to employees, directors and consultants [Member]" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]", "terseLabel": "Tabular List, Table" } } }, "auth_ref": [ "r277" ] }, "ifrs-full_TopOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TopOfRangeMember", "presentation": [ "http://www.evogene.com/role/FinancialInstrumentsNarrativeDetails", "http://www.evogene.com/role/Share-BasedCompensationScheduleOfAssumptionsUsedToValueOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Top of range [member]" } }, "en": { "role": { "documentation": "This member stands for top of a range." } } }, "auth_ref": [ "r29", "r55", "r64", "r74", "r122", "r200", "r201", "r318" ] }, "evgn_TotalAmountOfCertainConvertibleLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "TotalAmountOfCertainConvertibleLoans", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represent the amount of total amount Certain Convertible Loans", "label": "Total Amount Of Certain Convertible Loans" } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount", "terseLabel": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r269" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]", "terseLabel": "Total Shareholder Return Vs Peer Group" } } }, "auth_ref": [ "r276" ] }, "ifrs-full_TradeAndOtherCurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TradeAndOtherCurrentPayables", "crdr": "credit", "calculation": { "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Trade payables", "verboseLabel": "Trade Payables" } }, "en": { "role": { "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]" } } }, "auth_ref": [ "r169" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]", "terseLabel": "Trading Arrangement:" } } }, "auth_ref": [ "r297" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]", "terseLabel": "Trading Arrangements, by Individual" } } }, "auth_ref": [ "r299" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "TradingSymbol", "presentation": [ "http://www.evogene.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Adoption Date", "terseLabel": "Adoption Date" } } }, "auth_ref": [ "r300" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Duration", "terseLabel": "Arrangement Duration" } } }, "auth_ref": [ "r301" ] }, "ecd_TrdArrExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrExpirationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Expiration Date", "terseLabel": "Expiration Date" } } }, "auth_ref": [ "r301" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r299" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Title", "terseLabel": "Title" } } }, "auth_ref": [ "r299" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Securities Aggregate Available Amount", "terseLabel": "Aggregate Available" } } }, "auth_ref": [ "r302" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Termination Date", "terseLabel": "Termination Date" } } }, "auth_ref": [ "r300" ] }, "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TypesOfSharebasedPaymentArrangementsAxis", "presentation": [ "http://www.evogene.com/role/FinancialInstrumentsNarrativeDetails", "http://www.evogene.com/role/GeneralNarrativeDetails", "http://www.evogene.com/role/SHAREBASEDCOMPENSATIONScheduleOfRestrictedStockUnitsActivityDetails", "http://www.evogene.com/role/SUBSEQUENTEVENTSNarrativeDetails", "http://www.evogene.com/role/Share-BasedCompensationNarrativeDetails", "http://www.evogene.com/role/Share-BasedCompensationScheduleOfAssumptionsUsedToValueOptionsDetails", "http://www.evogene.com/role/Share-BasedCompensationScheduleOfSummarizedNumberOfShareOptionsDetails", "http://www.evogene.com/role/Share-BasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Types of share-based payment arrangements [axis]", "verboseLabel": "Types of share-based payment arrangements [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r75", "r142" ] }, "ifrs-full_TypesOfSharebasedPaymentArrangementsDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TypesOfSharebasedPaymentArrangementsDomain", "presentation": [ "http://www.evogene.com/role/FinancialInstrumentsNarrativeDetails", "http://www.evogene.com/role/GeneralNarrativeDetails", "http://www.evogene.com/role/SHAREBASEDCOMPENSATIONScheduleOfRestrictedStockUnitsActivityDetails", "http://www.evogene.com/role/SUBSEQUENTEVENTSNarrativeDetails", "http://www.evogene.com/role/Share-BasedCompensationNarrativeDetails", "http://www.evogene.com/role/Share-BasedCompensationScheduleOfAssumptionsUsedToValueOptionsDetails", "http://www.evogene.com/role/Share-BasedCompensationScheduleOfSummarizedNumberOfShareOptionsDetails", "http://www.evogene.com/role/Share-BasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Types of share-based payment arrangements [domain]" } }, "en": { "role": { "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used." } } }, "auth_ref": [ "r75", "r142" ] }, "evgn_UnallocatedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "UnallocatedMember", "presentation": [ "http://www.evogene.com/role/OperatingSegmentsScheduleOfRevenuesAndOperatingLossBySegmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Unallocated [Member]", "label": "Unallocated [Member]" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent", "terseLabel": "Underlying Security Market Price Change" } } }, "auth_ref": [ "r296" ] }, "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]", "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year" } } }, "auth_ref": [ "r265" ] }, "evgn_WarrantsAndPreFundedWarrantsLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "WarrantsAndPreFundedWarrantsLiabilitiesMember", "presentation": [ "http://www.evogene.com/role/FINANCIALINSTRUMENTSScheduleOfFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Warrants and pre funded warrants liabilities [Member].", "label": "Warrants And Pre Funded Warrants Liabilities [Member]", "verboseLabel": "Warrants and pre-funded warrants liabilities [Member]" } } }, "auth_ref": [] }, "evgn_WarrantsAndPreFundedWarrantsLiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "WarrantsAndPreFundedWarrantsLiabilityMember", "presentation": [ "http://www.evogene.com/role/FinancialInstrumentsNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Warrants And Pre Funded Warrants Liability [Member]", "label": "Warrants And Pre Funded Warrants Liability [Member]" } } }, "auth_ref": [] }, "evgn_WarrantsExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "WarrantsExercisePrice", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails", "http://www.evogene.com/role/SUBSEQUENTEVENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represent the warrants, exercise price.", "label": "Warrants Exercise Price", "terseLabel": "Exercise price per warrant", "verboseLabel": "Pre-funded warrants" } } }, "auth_ref": [] }, "ifrs-full_WarrantsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "WarrantsMember", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Warrants [member]" } }, "en": { "role": { "documentation": "This member stands for warrants." } } }, "auth_ref": [ "r310" ] }, "evgn_WeightedAverageExercisePriceAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "WeightedAverageExercisePriceAbstract", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfSummarizedNumberOfShareOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price Abstract", "verboseLabel": "Weighted Average Exercise Price" } } }, "auth_ref": [] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfSummarizedNumberOfShareOptionsDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Exercisable at end of year", "label": "Weighted average exercise price of share options exercisable in share-based payment arrangement" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r71", "r140" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfSummarizedNumberOfShareOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Exercised" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r69", "r138" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfSummarizedNumberOfShareOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Forfeited" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r68", "r137" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfSummarizedNumberOfShareOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Grants", "terseLabel": "Granted" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r67", "r136" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationScheduleOfShareOptionsOutstandingDetails", "http://www.evogene.com/role/Share-BasedCompensationScheduleOfSummarizedNumberOfShareOptionsDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Outstanding at end of year", "periodStartLabel": "Outstanding on beginning of year", "label": "Weighted average exercise price" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r66", "r70", "r135", "r139" ] }, "evgn_WeightedAverageFairValueAtMeasurementDateOtherEquityInstrumentsForfeited": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "WeightedAverageFairValueAtMeasurementDateOtherEquityInstrumentsForfeited", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/SHAREBASEDCOMPENSATIONScheduleOfRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value at measurement date, other equity instruments Forfeited", "label": "Weighted Average Fair Value At Measurement Date, Other Equity Instruments Forfeited", "verboseLabel": "Weighted average grant date fair value Forfeited" } } }, "auth_ref": [] }, "ifrs-full_WeightedAverageFairValueAtMeasurementDateOtherEquityInstrumentsGranted": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "WeightedAverageFairValueAtMeasurementDateOtherEquityInstrumentsGranted", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/SHAREBASEDCOMPENSATIONScheduleOfRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average fair value at measurement date, other equity instruments granted", "verboseLabel": "Weighted average grant date fair value Granted" } }, "en": { "role": { "documentation": "The weighted average fair value at the measurement date of granted equity instruments other than share options. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r78" ] }, "evgn_WeightedAverageFairValueAtMeasurementDateOtherEquityInstrumentsOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "WeightedAverageFairValueAtMeasurementDateOtherEquityInstrumentsOutstanding", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/SHAREBASEDCOMPENSATIONScheduleOfRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value at measurement date, other equity instruments outstanding", "periodEndLabel": "Weighted average grant date fair value Outstanding", "periodStartLabel": "Weighted average grant date fair value Outstanding", "label": "Weighted Average Fair Value At Measurement Date, Other Equity Instruments Outstanding" } } }, "auth_ref": [] }, "evgn_WeightedAverageFairValueAtMeasurementDateOtherEquityInstrumentsVested": { "xbrltype": "monetaryItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "WeightedAverageFairValueAtMeasurementDateOtherEquityInstrumentsVested", "crdr": "credit", "presentation": [ "http://www.evogene.com/role/SHAREBASEDCOMPENSATIONScheduleOfRestrictedStockUnitsActivityDetails" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at the measurement date of vested equity instruments other than share options.", "label": "Weighted Average Fair Value At Measurement Date, Other Equity Instruments Vested", "verboseLabel": "Weighted average grant date fair value Vested" } } }, "auth_ref": [] }, "evgn_WeightedAverageFairValueOfShareOptionsGrantedInSharebasedPaymentArrangement": { "xbrltype": "perShareItemType", "nsuri": "http://www.evogene.com/20260630", "localname": "WeightedAverageFairValueOfShareOptionsGrantedInSharebasedPaymentArrangement", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value of options granted.", "label": "Weighted Average Fair Value Of Share Options Granted In Sharebased Payment Arrangement", "verboseLabel": "Weighted average fair value of options granted" } } }, "auth_ref": [] }, "ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019": { "xbrltype": "durationItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019", "presentation": [ "http://www.evogene.com/role/Share-BasedCompensationNarrativeDetails", "http://www.evogene.com/role/Share-BasedCompensationScheduleOfShareOptionsOutstandingDetails", "http://www.evogene.com/role/Share-BasedCompensationScheduleOfSummarizedNumberOfShareOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average outstanding remaining contractual term of options", "terseLabel": "Weighted average remaining contractual life (in Yrs.)", "verboseLabel": "The weighted average remaining contractual life for the share options" } }, "en": { "role": { "documentation": "The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r74" ] }, "ifrs-full_WeightedAverageSharePrice2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "WeightedAverageSharePrice2019", "presentation": [ "http://www.evogene.com/role/GeneralNarrativeDetails", "http://www.evogene.com/role/SUBSEQUENTEVENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average share price", "terseLabel": "Weighted average share price" } }, "en": { "role": { "documentation": "The weighted average share price. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r73" ] }, "ifrs-full_WeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "WeightedAverageShares", "presentation": [ "http://www.evogene.com/role/ConsolidatedStatementsOfProfitOrLoss" ], "lang": { "en-us": { "role": { "label": "Weighted average number of shares used in computing basic and diluted loss per share", "terseLabel": "Weighted average number of ordinary shares used in computing basic loss per share", "verboseLabel": "Weighted number of shares" } }, "en": { "role": { "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor." } } }, "auth_ref": [ "r19" ] }, "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]", "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested" } } }, "auth_ref": [ "r263" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "10", "IssueDate": "2025-01-01", "Paragraph": "21", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2025-en-r&anchor=para_21&doctype=Standard", "URIDate": "2025-03-27" }, "r1": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "10", "IssueDate": "2025-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI", "URIDate": "2025-03-27" }, "r2": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_79&doctype=Standard", "URIDate": "2025-03-27" }, "r3": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2025-03-27" }, "r4": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_c_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r5": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2025-03-27" }, "r6": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "36", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2025-en-r&anchor=para_36_b&doctype=Standard", "URIDate": "2025-03-27" }, "r7": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "36", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2025-en-r&anchor=para_36_e&doctype=Standard", "URIDate": "2025-03-27" }, "r8": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "20", "IssueDate": "2025-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS20_g39-39_TI", "URIDate": "2025-03-27" }, "r9": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2025-01-01", "Paragraph": "19", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_19&doctype=Standard", "URIDate": "2025-03-27" }, "r10": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "26", "IssueDate": "2025-01-01", "Paragraph": "35", "Subparagraph": "b", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2025-en-r&anchor=para_35_b_viii&doctype=Standard", "URIDate": "2025-03-27" }, "r11": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2025-01-01", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_10&doctype=Standard", "URIDate": "2025-03-27" }, "r12": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2025-01-01", "Paragraph": "16", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r13": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2025-01-01", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2025-03-27" }, "r14": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2025-01-01", "Paragraph": "17", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r15": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2025-01-01", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2025-03-27" }, "r16": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2025-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_66&doctype=Standard", "URIDate": "2025-03-27" }, "r17": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2025-01-01", "Paragraph": "67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_67&doctype=Standard", "URIDate": "2025-03-27" }, "r18": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2025-01-01", "Paragraph": "68", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_68&doctype=Standard", "URIDate": "2025-03-27" }, "r19": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2025-01-01", "Paragraph": "70", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_b&doctype=Standard", "URIDate": "2025-03-27" }, "r20": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2025-01-01", "Paragraph": "130", "Subparagraph": "d", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_130_d_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r21": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "126", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_126&doctype=Standard", "URIDate": "2025-03-27" }, "r22": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_10&doctype=Standard", "URIDate": "2025-03-27" }, "r23": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20&doctype=Standard", "URIDate": "2025-03-27" }, "r24": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_25&doctype=Standard", "URIDate": "2025-03-27" }, "r25": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_28&doctype=Standard", "URIDate": "2025-03-27" }, "r26": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_31&doctype=Standard", "URIDate": "2025-03-27" }, "r27": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35&doctype=Standard", "URIDate": "2025-03-27" }, "r28": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "40", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_40_b&doctype=Standard", "URIDate": "2025-03-27" }, "r29": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "44H", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_44H_b_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r30": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard", "URIDate": "2025-03-27" }, "r31": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "50", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_50_d&doctype=Standard", "URIDate": "2025-03-27" }, "r32": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2025-03-27" }, "r33": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "24", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2025-03-27" }, "r34": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_32_a_i&doctype=Standard", "URIDate": "2025-03-27" }, "r35": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_32_a_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r36": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "10", "IssueDate": "2025-01-01", "Paragraph": "22", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2025-en-r&anchor=para_22&doctype=Standard", "URIDate": "2025-03-27" }, "r37": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "12", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_12_e&doctype=Standard", "URIDate": "2025-03-27" }, "r38": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "12", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_12_f&doctype=Standard", "URIDate": "2025-03-27" }, "r39": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "19B", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_19B_c&doctype=Standard", "URIDate": "2025-03-27" }, "r40": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B10", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B10_a&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r41": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r42": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r43": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r44": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r45": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "v", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r46": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_vi&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r47": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_vii&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r48": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B13", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r49": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B13", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r50": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B16", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B16&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r51": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B4", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r52": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "93", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_a&doctype=Standard", "URIDate": "2025-03-27" }, "r53": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "93", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_b&doctype=Standard", "URIDate": "2025-03-27" }, "r54": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "93", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_e&doctype=Standard", "URIDate": "2025-03-27" }, "r55": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "14", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2025-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2025-03-27" }, "r56": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2025-01-01", "Paragraph": "113", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_113_a&doctype=Standard", "URIDate": "2025-03-27" }, "r57": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2025-01-01", "Paragraph": "114", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_114&doctype=Standard", "URIDate": "2025-03-27" }, "r58": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2025-01-01", "Paragraph": "115", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_115&doctype=Standard", "URIDate": "2025-03-27" }, "r59": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2025-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS15_g110-129_TI", "URIDate": "2025-03-27" }, "r60": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2025-01-01", "Section": "Presentation", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS15_g105-109_TI", "URIDate": "2025-03-27" }, "r61": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "47", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_47_a&doctype=Standard", "URIDate": "2025-03-27" }, "r62": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2025-03-27" }, "r63": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "53", "Subparagraph": "j", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53_j&doctype=Standard", "URIDate": "2025-03-27" }, "r64": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "120", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_120&doctype=Standard", "URIDate": "2025-03-27" }, "r65": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "44", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_44&doctype=Standard", "URIDate": "2025-03-27" }, "r66": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r67": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r68": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r69": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_iv&doctype=Standard", "URIDate": "2025-03-27" }, "r70": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_vi&doctype=Standard", "URIDate": "2025-03-27" }, "r71": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_vii&doctype=Standard", "URIDate": "2025-03-27" }, "r72": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "45", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b&doctype=Standard", "URIDate": "2025-03-27" }, "r73": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "45", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_c&doctype=Standard", "URIDate": "2025-03-27" }, "r74": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "45", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_d&doctype=Standard", "URIDate": "2025-03-27" }, "r75": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard", "URIDate": "2025-03-27" }, "r76": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "47", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_a_i&doctype=Standard", "URIDate": "2025-03-27" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "47", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_a&doctype=Standard", "URIDate": "2025-03-27" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2025-03-27" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "50", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_50&doctype=Standard", "URIDate": "2025-03-27" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "51", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_51_a&doctype=Standard", "URIDate": "2025-03-27" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2025-01-01", "Paragraph": "B64", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2025-01-01", "Paragraph": "B67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B67&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_a&doctype=Standard", "URIDate": "2025-03-27" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_c&doctype=Standard", "URIDate": "2025-03-27" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Section": "Presentation and disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS05_g30-42_TI", "URIDate": "2025-03-27" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_25&doctype=Standard", "URIDate": "2025-03-27" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_31&doctype=Standard", "URIDate": "2025-03-27" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "35H", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35H&doctype=Standard", "URIDate": "2025-03-27" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "35K", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35K&doctype=Standard", "URIDate": "2025-03-27" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "35M", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35M&doctype=Standard", "URIDate": "2025-03-27" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "36", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_36&doctype=Standard", "URIDate": "2025-03-27" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_7&doctype=Standard", "URIDate": "2025-03-27" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Section": "Scope", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI", "URIDate": "2025-03-27" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "23", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_a&doctype=Standard", "URIDate": "2025-03-27" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "23", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_g&doctype=Standard", "URIDate": "2025-03-27" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "23", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_h&doctype=Standard", "URIDate": "2025-03-27" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23&doctype=Standard", "URIDate": "2025-03-27" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2025-03-27" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_a&doctype=Standard", "URIDate": "2025-03-27" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2025-03-27" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_c&doctype=Standard", "URIDate": "2025-03-27" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_d&doctype=Standard", "URIDate": "2025-03-27" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_e&doctype=Standard", "URIDate": "2025-03-27" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28&doctype=Standard", "URIDate": "2025-03-27" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_32&doctype=Standard", "URIDate": "2025-03-27" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_33_a&doctype=Standard", "URIDate": "2025-03-27" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_33&doctype=Standard", "URIDate": "2025-03-27" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_34&doctype=Standard", "URIDate": "2025-03-27" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI", "URIDate": "2025-03-27" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103&doctype=Standard", "URIDate": "2025-03-27" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "104", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_104&doctype=Standard", "URIDate": "2025-03-27" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "115", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115_i&doctype=Standard", "URIDate": "2025-03-27" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "128", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_128&doctype=Standard", "URIDate": "2025-03-27" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "138", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138&doctype=Standard", "URIDate": "2025-03-27" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "160", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a_i&doctype=Standard", "URIDate": "2025-03-27" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "160", "Subparagraph": "a", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "160", "Subparagraph": "a", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a_iv&doctype=Standard", "URIDate": "2025-03-27" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "160", "Subparagraph": "a", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a_vii&doctype=Standard", "URIDate": "2025-03-27" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "164", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_164_b&doctype=Standard", "URIDate": "2025-03-27" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "164", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_164_d&doctype=Standard", "URIDate": "2025-03-27" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "168", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_168_b_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "169", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_169&doctype=Standard", "URIDate": "2025-03-27" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "190", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_190&doctype=Standard", "URIDate": "2025-03-27" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "192", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_192&doctype=Standard", "URIDate": "2025-03-27" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "194", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_c_i&doctype=Standard", "URIDate": "2025-03-27" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "194", "Subparagraph": "c", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_c_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "200", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e&doctype=Standard", "URIDate": "2025-03-27" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "231", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_231&doctype=Standard", "URIDate": "2025-03-27" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2025-03-27" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "24", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2025-03-27" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "266", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_266&doctype=Standard", "URIDate": "2025-03-27" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_28_a_i&doctype=Standard", "URIDate": "2025-03-27" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_28_a_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "31", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "31", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "31", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "31", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_iv&doctype=Standard", "URIDate": "2025-03-27" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "31", "Subparagraph": "b", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_vi&doctype=Standard", "URIDate": "2025-03-27" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "31", "Subparagraph": "b", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_vii&doctype=Standard", "URIDate": "2025-03-27" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "31", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b&doctype=Standard", "URIDate": "2025-03-27" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31&doctype=Standard", "URIDate": "2025-03-27" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "34", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_34_a&doctype=Standard", "URIDate": "2025-03-27" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35&doctype=Standard", "URIDate": "2025-03-27" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "43", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_43&doctype=Standard", "URIDate": "2025-03-27" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_66&doctype=Standard", "URIDate": "2025-03-27" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "71", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_71&doctype=Standard", "URIDate": "2025-03-27" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "75", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_75_a&doctype=Standard", "URIDate": "2025-03-27" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "89", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_89&doctype=Standard", "URIDate": "2025-03-27" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "95", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95_a&doctype=Standard", "URIDate": "2025-03-27" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "95", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95_b&doctype=Standard", "URIDate": "2025-03-27" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B10", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a_i&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B10", "Subparagraph": "a", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a_iii&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B10", "Subparagraph": "a", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a_iv&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B10", "Subparagraph": "a", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a_vii&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B12", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B12&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B9", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_e&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B9", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_f&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_103&doctype=Standard", "URIDate": "2025-03-27" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d_i&doctype=Standard", "URIDate": "2025-03-27" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106&doctype=Standard", "URIDate": "2025-03-27" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "107", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_107&doctype=Standard", "URIDate": "2025-03-27" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "51", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_51&doctype=Standard", "URIDate": "2025-03-27" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_a&doctype=Standard", "URIDate": "2025-03-27" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_e&doctype=Standard", "URIDate": "2025-03-27" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_g&doctype=Standard", "URIDate": "2025-03-27" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_i&doctype=Standard", "URIDate": "2025-03-27" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "k", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_k&doctype=Standard", "URIDate": "2025-03-27" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "q", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_q&doctype=Standard", "URIDate": "2025-03-27" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "r", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_r&doctype=Standard", "URIDate": "2025-03-27" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard", "URIDate": "2025-03-27" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_66&doctype=Standard", "URIDate": "2025-03-27" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "69", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_69&doctype=Standard", "URIDate": "2025-03-27" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "78", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_d&doctype=Standard", "URIDate": "2025-03-27" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard", "URIDate": "2025-03-27" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a_i&doctype=Standard", "URIDate": "2025-03-27" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a_iv&doctype=Standard", "URIDate": "2025-03-27" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a_vii&doctype=Standard", "URIDate": "2025-03-27" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "81A", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81A_a&doctype=Standard", "URIDate": "2025-03-27" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "81B", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81B_a_i&doctype=Standard", "URIDate": "2025-03-27" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "81B", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81B_a_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "82", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_a&doctype=Standard", "URIDate": "2025-03-27" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "82", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_b&doctype=Standard", "URIDate": "2025-03-27" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "82", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_c&doctype=Standard", "URIDate": "2025-03-27" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "82", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_d&doctype=Standard", "URIDate": "2025-03-27" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "82", "Subparagraph": "ea", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_ea&doctype=Standard", "URIDate": "2025-03-27" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "98", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_98_a&doctype=Standard", "URIDate": "2025-03-27" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "98", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_98_e&doctype=Standard", "URIDate": "2025-03-27" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "99", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_99&doctype=Standard", "URIDate": "2025-03-27" }, "r192": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "138", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138_a&doctype=Standard", "URIDate": "2025-03-27" }, "r193": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "138", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138_d&doctype=Standard", "URIDate": "2025-03-27" }, "r194": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "24", "IssueDate": "2025-01-01", "Paragraph": "21", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_21_c&doctype=Standard", "URIDate": "2025-03-27" }, "r195": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "32", "IssueDate": "2025-01-01", "Paragraph": "IE33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2025-en-r&anchor=para_IE33&doctype=Illustrative%20Examples", "URIDate": "2025-03-27" }, "r196": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "16", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_16_a&doctype=Standard", "URIDate": "2025-03-27" }, "r197": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2025-03-27" }, "r198": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2025-03-27" }, "r199": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B10", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r200": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "B6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_B6&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r201": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "IE63", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_IE63&doctype=Illustrative%20Examples", "URIDate": "2025-03-27" }, "r202": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "15", "IssueDate": "2025-01-01", "Paragraph": "B89", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r203": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "113", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_113_b&doctype=Standard", "URIDate": "2025-03-27" }, "r204": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "96", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_96_b&doctype=Standard", "URIDate": "2025-03-27" }, "r205": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "96", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_96_c&doctype=Standard", "URIDate": "2025-03-27" }, "r206": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23&doctype=Standard", "URIDate": "2025-03-27" }, "r207": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2025-03-27" }, "r208": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "103", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103_b&doctype=Standard", "URIDate": "2025-03-27" }, "r209": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "234", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_234_c&doctype=Standard", "URIDate": "2025-03-27" }, "r210": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B9", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_b&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r211": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B9", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_f&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r212": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "102", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_102&doctype=Standard", "URIDate": "2025-03-27" }, "r213": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_103&doctype=Standard", "URIDate": "2025-03-27" }, "r214": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_108&doctype=Standard", "URIDate": "2025-03-27" }, "r215": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "68", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_68&doctype=Standard", "URIDate": "2025-03-27" }, "r216": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_b&doctype=Standard", "URIDate": "2025-03-27" }, "r217": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard", "URIDate": "2025-03-27" }, "r218": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "IG6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_IG6&doctype=Implementation%20Guidance", "URIDate": "2025-03-27" }, "r219": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r220": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r221": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r222": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r223": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r224": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r225": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r226": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r227": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r228": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r229": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r230": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r231": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r232": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r233": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r234": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r235": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r236": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r237": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r238": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r239": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r240": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r241": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r242": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r243": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r244": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r245": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r246": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r247": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r248": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r249": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r250": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r251": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r252": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r253": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r254": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r255": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r256": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r257": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r258": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r259": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r260": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r261": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r262": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "ii" }, "r263": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "i" }, "r264": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "ii" }, "r265": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iii" }, "r266": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iv" }, "r267": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "v" }, "r268": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "vi" }, "r269": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r270": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r271": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r272": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r273": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r274": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r275": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r276": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r277": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r278": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r279": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r280": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r281": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r282": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r283": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r284": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r285": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r286": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r287": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r288": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r289": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r290": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r291": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r292": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r293": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r294": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r295": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r296": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r297": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r298": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r299": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r300": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r301": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r302": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r303": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r304": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Number": "229", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1" }, "r305": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "A", "Number": "229" }, "r306": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Number": "229" }, "r307": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "i", "Number": "229" }, "r308": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r309": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r310": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "33", "IssueDate": "2025-01-01", "Paragraph": "70", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_c&doctype=Standard", "URIDate": "2025-03-27" }, "r311": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "16", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_16&doctype=Standard", "URIDate": "2025-03-27" }, "r312": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17&doctype=Standard", "URIDate": "2025-03-27" }, "r313": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "20", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20_a&doctype=Standard", "URIDate": "2025-03-27" }, "r314": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "20", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20_b&doctype=Standard", "URIDate": "2025-03-27" }, "r315": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20&doctype=Standard", "URIDate": "2025-03-27" }, "r316": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35&doctype=Standard", "URIDate": "2025-03-27" }, "r317": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard", "URIDate": "2025-03-27" }, "r318": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_7&doctype=Standard", "URIDate": "2025-03-27" }, "r319": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_34&doctype=Standard", "URIDate": "2025-03-27" }, "r320": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "10", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_10_e&doctype=Standard", "URIDate": "2025-03-27" }, "r321": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d&doctype=Standard", "URIDate": "2025-03-27" }, "r322": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "112", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_112_c&doctype=Standard", "URIDate": "2025-03-27" }, "r323": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard", "URIDate": "2025-03-27" }, "r324": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "78", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78&doctype=Standard", "URIDate": "2025-03-27" }, "r325": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "85", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_85&doctype=Standard", "URIDate": "2025-03-27" } } }